	Reportable Segment	Reportable Segment	Reportable Segment

	Label and Graphic Materials	Retail Branding and Information Solutions	Industrial and Healthcare Materials

BUSINESSES	Label and Packaging Materials Graphics Solutions Reflective Solutions	Retail Branding and Information Solutions Printer Solutions	Performance Tapes Fastener Solutions Vancive Medical Technologies

2018 SALES IN MILLIONS	$4,851	$1,613	$695

% OF SALES	68%	22%	10%

GLOBAL BRAND	Avery Dennison® Fasson®	Avery Dennison® Monarch®	Avery Dennison® Vancive Medical Technologies®

DESCRIPTION	The technologies and materials of our Label and Graphic Materials businesses enhance brands' shelf, store, and street appeal; inform shoppers of ingredients; protect brand security; improve operational efficiency and customer product performance; and provide visual information that enhances safety.	Our Retail Branding and Information Solutions businesses provide intelligent, creative, and sustainable solutions that elevate brands and accelerate performance primarily through the global retail supply chain.	Our Industrial and Healthcare Materials businesses provide tape products, including coated and adhesive transfer tapes; fasteners, primarily precision-extruded and injection-molded plastic devices; and wound care, ostomy, surgical, and electromedical device products for manufacturers, clinicians, and patients.

PRODUCTS/SOLUTIONS	Pressure-sensitive labeling materials; packaging materials and solutions; roll-fed sleeves; engineered films; graphic imaging media; reflective materials	Creative services; brand embellishments; graphic tickets; tags and labels; sustainable packaging; inventory visibility and loss prevention solutions; data management services; price tickets; printers and scanners; brand protection and security solutions; intelligent labeling solutions with unique digital identities including RFID and sensor technologies	Pressure-sensitive tapes for automotive, building, and construction; electronics; general industrial; diaper tapes and closures; fasteners; skin-contact adhesives; surgical, wound care, ostomy, and securement products; medical barrier films

MARKET SEGMENTS	Food; beverage; wine and spirits; home and personal care products; pharmaceuticals; durables; fleet vehicle/automotive; architectural/ retail; promotional/advertising; traffic; safety; transportation	Apparel manufacturing and retail supply chain; food service and supply chain; hard goods and supply chain; pharmaceutical supply chain; logistics; food and beauty brands and retailers' supply chain to customers; aviation asset tracking	Original equipment manufacturing; personal care; electronics; building and construction; retail supply chain; medical

CUSTOMERS	Label converters; package designers; packaging engineers and manufacturers; industrial manufacturers; printers; distributors; designers; advertising agencies; government agencies; sign manufacturers; graphics vendors	Apparel and footwear brands; manufacturers and retailers; food service, grocery, and pharmaceutical supply chains; consumer goods brands; automotive manufacturers; transportation companies; airlines and airports	Tape converters; original equipment manufacturers; original design manufacturers; construction firms; personal care product manufacturers; manufacturers and retailers; medical device manufacturers

WEBSITES	www.label.averydennison.com www.graphics.averydennison.com www.reflectives.averydennison.com	www.rbis.averydennison.com www.rfid.averydennison.com	www.tapes.averydennison.com www.vancive.averydennison.com

LEADERS	Georges Gravanis President Label and Graphic Materials	Deon Stander Vice President and General Manager Retail Branding and Information Solutions	Greg Lovins Senior Vice President and Chief Financial Officer; Interim General Manager, Industrial and Healthcare Materials

The matters discussed in this Annual Report contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, which are not statements of historical fact, contain estimates, assumptions, projections and/or expectations regarding future events, which may or may not occur. Words such as "aim," "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "foresee," "guidance," "intend," "may," "might," "objective," "plan," "potential," "project," "seek," "shall," "should," "target," "will," "would," or variations thereof, and other expressions that refer to future events and trends, identify forward-looking statements. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties, which could cause our actual results to differ materially from the expected results, performance or achievements expressed or implied by such forward-looking statements.

Certain risks and uncertainties are discussed in more detail under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the fiscal year ended December 29, 2018 and include, but are not limited to, risks and uncertainties relating to the following: fluctuations in demand affecting sales to customers; worldwide and local economic conditions; changes in political conditions; changes in governmental laws and regulations; fluctuations in foreign currency exchange rates and other risks associated with foreign operations, including in emerging markets; the financial condition and inventory strategies of customers; changes in our markets due to competitive conditions, technological developments, laws and regulations, and customer preferences; fluctuations in cost and availability of raw materials; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; the impact of competitive products and pricing; loss of significant contracts or customers; collection of receivables from customers; selling prices; business mix shift; execution and integration of acquisitions; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; amounts of future dividends and share repurchases; customer and supplier concentrations; successful implementation of new manufacturing technologies and installation of manufacturing equipment; disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; data security breaches; volatility of financial markets; impairment of capitalized assets, including goodwill and other intangibles; credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; fluctuations in interest and tax rates; changes in tax laws and regulations including the U.S. Tax Cuts and Jobs Act, and uncertainties associated with interpretations of such laws and regulations; outcome of tax audits; fluctuations in pension, insurance, and employee benefit costs, including risks related to the termination of our U.S. pension plan; the impact of legal and regulatory proceedings, including with respect to environmental, health and safety; protection and infringement of intellectual property; the impact of epidemiological events on the economy and our customers and suppliers; acts of war, terrorism, and natural disasters; and other factors.

We believe that the most significant risk factors that could affect our financial performance in the near-term include: (1) the impacts of global economic conditions and political uncertainty on underlying demand for our products and foreign currency fluctuations; (2) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through selling price increases, without a significant loss of volume; (3) competitors' actions, including pricing, expansion in key markets, and product offerings; and (4) the execution and integration of acquisitions.

Our forward-looking statements are made only as of the date hereof. We assume no duty to update these forward-looking statements to reflect new, changed or unanticipated events or circumstances, other than as may be required by law.


(Dollars in millions, except percentages		2018				2017				2016				2015				2014	(1)

and per share amounts)		Dollars		%		Dollars		%		Dollars		%		Dollars		%		Dollars		%

For the Year
Net sales	$	7,159.0		100.0	$	6,613.8		100.0	$	6,086.5		100.0	$	5,966.9		100.0	$	6,330.3		100.0
Gross profit		1,915.5		26.8		1,812.2		27.4		1,699.7		27.9		1,645.8		27.6		1,651.2		26.1
Marketing, general and administrative expense		1,127.5		15.7		1,105.2		16.7		1,085.7		17.8		1,087.8		18.2		1,138.3		18.0
Other expense, net(2)(3)		69.9		1.0		36.5		.6		23.8		.4		64.5		1.1		66.6		1.1
Interest expense		58.5		.8		63.0		1.0		59.9		1.0		60.5		1.0		63.3		1.0
Other non-operating expense(3)		104.8		1.5		18.0		.3		53.2		.9		24.1		.4		22.2		.4
Income from continuing operations before taxes		554.8		7.7		589.5		8.9		477.1		7.8		408.9		6.9		360.8		5.7
Provision for income taxes(4)		85.4		1.2		307.7		4.7		156.4		2.6		134.5		2.3		113.5		1.8
Equity method investment net losses		(2.0	)	N/A		–		N/A		–		N/A		–		N/A		–		N/A
Income from continuing operations		467.4		6.5		281.8		4.3		320.7		5.3		274.4		4.6		247.3		3.9
Loss from discontinued operations, net of tax		–		N/A		–		N/A		–		N/A		(.1	)	N/A		(2.2	)	N/A
Net income		467.4		6.5		281.8		4.3		320.7		5.3		274.3		4.6		245.1		3.9

		2018				2017				2016				2015				2014

Per Share Information
Income per common share from continuing operations	$	5.35			$	3.19			$	3.60			$	3.01			$	2.64
Loss per common share from discontinued operations		–				–				–				–				(.03	)
Net income per common share		5.35				3.19				3.60				3.01				2.61
Income per common share from continuing operations, assuming dilution		5.28				3.13				3.54				2.95				2.58
Loss per common share from discontinued operations, assuming dilution		–				–				–				–				(.02	)
Net income per common share, assuming dilution		5.28				3.13				3.54				2.95				2.56
Dividends per common share		2.01				1.76				1.60				1.46				1.34
Weighted average number of common shares outstanding (in millions)		87.3				88.3				89.1				91.0				93.8
Weighted average number of common shares outstanding, assuming dilution (in millions)		88.6				90.1				90.7				92.9				95.7

At End of Year
Property, plant and equipment, net	$	1,137.4			$	1,097.9			$	915.2			$	847.9			$	875.3
Total assets		5,177.5				5,136.9				4,396.4				4,133.7				4,356.9
Long-term debt and capital leases		1,771.6				1,316.3				713.4				963.6				940.1
Total debt		1,966.2				1,581.7				1,292.5				1,058.9				1,144.4
Shareholders' equity(5)		955.1				1,046.2				925.5				965.7				1,047.7

Other Information
Depreciation and amortization expense	$	181.0			$	178.7			$	180.1			$	188.3			$	201.6
Research and development expense		98.2				93.4				89.7				91.9				102.5
Effective tax rate(4)(6)		15.4	%			52.2	%			32.8	%			32.9	%			31.5	%

(1): Results for 2014 reflected a 53-week period.
(2): Included pre-tax charges for severance and related costs, asset impairment charges, lease and other contract cancellation costs, Argentine peso remeasurement transition loss, reversal of acquisition-related contingent consideration, and other items.
(3): In the first quarter of 2018, we adopted Accounting Standards Update (ASU) No. 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, on a retrospective basis. This ASU requires employers with defined benefit plans to present the components of net periodic benefit cost, other than service cost, outside of operating income. Prior year results have been reclassified as required by the ASU.
(4): In the fourth quarter of 2018, we finalized our provisional estimate as defined under SEC Staff Accounting Bulletin No. 118 related to the U.S. Tax Cuts and Jobs Act ("TCJA") of 2017.
(5): Amounts in 2014 and 2015 included continuing and discontinued operations.
(6): Amounts in 2014 and 2015 included continuing operations only.

The graph below compares the cumulative stockholder return on our common stock, including the reinvestment of dividends, with the return on the S&P 500® Stock Index, the average return (weighted by market capitalization) of the S&P 500® Materials and Industrials subsets (the "Market Basket"), and the median return of the Market Basket, in each case for the five-year period ending December 31, 2018.

Historical stock price performance is not necessarily indicative of future stock price performance.

Management's Discussion and Analysis of
Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management's views on our financial condition and results of operations, should be read in conjunction with the accompanying Consolidated Financial Statements and notes thereto, and includes the following sections:

We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are useful to their assessments of our performance and operating trends, as well as liquidity.

Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, legal settlements, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. These non-GAAP financial measures are used internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.

Normally, our fiscal years consist of 52 weeks, but every fifth or sixth fiscal year consists of 53 weeks. Our 2018, 2017, and 2016 fiscal years consisted of 52-week periods ending December 29, 2018, December 30, 2017, and December 31, 2016, respectively.

Management's Discussion and Analysis of
Financial Condition and Results of Operations

In both years, net sales increased on an organic basis primarily due to higher volume.

Net income increased from approximately $282 million in 2017 to approximately $467 million in 2018. The major factors affecting the change in net income in 2018 compared to 2017 were:

In July 2018, our Board of Directors ("Board") approved the termination of the Avery Dennison Pension Plan (the "ADPP"), a U.S. defined benefit plan, effective as of September 28, 2018. In connection with the termination, we contributed $200 million to the ADPP in August 2018 using U.S. commercial paper borrowings. During the fourth quarter of 2018, we settled approximately $152 million of the ADPP liability through lump-sum payments from existing plan assets to eligible participants who elected to receive them and recorded approximately $85 million of non-cash charges associated with these settlements. We expect to settle the remaining liability of approximately $792 million through the purchase of group annuity contract(s) from one or more yet-to-be-identified highly rated insurance companies in the first half of 2019. Upon transfer of this remaining liability, we expect to recognize an additional $490 million of non-cash pre-tax charges and related tax benefits of $190 million. As of December 29, 2018, the ADPP was underfunded by approximately $57 million.

In April 2018, we approved a restructuring plan (the "2018 Plan") associated with the consolidation of the European footprint of our Label and Graphic Materials ("LGM") reportable segment that is expected to result in a headcount reduction of approximately 400 positions related to the closure of a manufacturing facility. This reduction is expected to be partially offset by headcount additions in other locations, resulting in a net reduction of approximately 150 positions. During fiscal year 2018, we recorded $55.2 million in restructuring charges, net of reversals, related to the 2018 Plan. These charges consisted of severance and related costs for the reduction of approximately 345 positions to date, as well as asset impairment charges. The vast majority of the cash payments associated with these charges is expected to be made in 2019. We anticipate annualized savings from the 2018 Plan of approximately $25 million, beginning in the second half of 2019, and expect the 2018 Plan to be substantially complete by the end of 2019.

In addition to restructuring charges recorded under the 2018 Plan, we recorded $4.2 million in restructuring charges in the fourth quarter 2018 related to our 2018/2019 Actions. These charges consisted of severance and related costs for the reduction of approximately 85 positions, as well as asset impairment charges.

During fiscal year 2018, we recorded $14.3 million in restructuring charges, net of reversals, related to restructuring actions initiated during the third quarter of 2015. These charges consisted of severance and related costs for the reduction of approximately 625 positions, lease cancellation costs, and asset impairment charges.

During fiscal year 2017, we recorded $34.1 million in restructuring charges, net of reversals, related to our 2015/2016 Actions. These charges consisted of severance and related costs for the reduction of approximately 920 positions, lease cancellation costs, and asset impairment charges.

The activities and related charges and payments for our 2015/2016 Actions were substantially completed in 2018.

During fiscal year 2018, we realized approximately $30 million in savings, net of transition costs, primarily from our 2015/2016 Actions.

We anticipate incremental savings from restructuring, net of transition costs, of approximately $35 million in 2019, primarily related to our 2018/2019 Actions. We estimate cash restructuring costs of at least $20 million in 2019.

Restructuring charges were included in "Other expense, net" in the Consolidated Statements of Income. Refer to Note 13, "Cost Reduction Actions," to the Consolidated Financial Statements for more information.

During 2017, we completed the stock acquisitions of Yongle Tape Ltd. ("Yongle Tape") and Finesse Medical Limited, and the net asset acquisition of Hanita Coatings Rural Cooperative Association Limited and stock acquisition of certain of its subsidiaries (collectively, the "2017 Acquisitions"), which were not material, individually or in the aggregate, to the Consolidated Financial Statements.

In 2016, we completed the acquisition of the European business of Mactac ("Mactac"), which was not material to the Consolidated Financial Statements. Refer to Note 2, "Acquisitions," to the Consolidated Financial Statements for more information

Refer to Note 1, "Summary of Significant Accounting Policies," to the Consolidated Financial Statements for this information.

Management's Discussion and Analysis of
Financial Condition and Results of Operations

In 2018, net cash provided by operating activities decreased compared to 2017 primarily due to our $200 million contribution to the ADPP in connection with its termination, as well as higher income tax payments, net of refunds, changes in operational working capital, and higher incentive compensation payments, partially offset by higher net income. In 2018, free cash flow increased compared to 2017 primarily due to higher cash provided by operating activities adjusted for the ADPP contribution and higher net proceeds from insurance and sales of investments and proceeds from sales of property, plant and equipment, partially offset by higher capital expenditures.

In 2017, net cash provided by operating activities increased compared to 2016 primarily due to higher income before taxes, as well as lower pension plan contributions, partially offset by higher income tax payments, net of refunds. Net cash provided by operating activities in 2017 reflected the impact of our adoption of the accounting guidance update related to stock-based payments. Free cash flow increased due to higher net cash flow provided by operating activities, partially offset by higher net capital and software expenditures.

Certain factors that we believe may contribute to our 2019 results are described below:

(In millions, except percentages)	2018			2017			2016


Net sales	$	7,159.0		$	6,613.8		$	6,086.5
Cost of products sold		5,243.5			4,801.6			4,386.8

Gross profit		1,915.5			1,812.2			1,699.7
Marketing, general and administrative expense		1,127.5			1,105.2			1,085.7
Other expense, net		69.9			36.5			23.8
Interest expense		58.5			63.0			59.9
Other non-operating expense		104.8			18.0			53.2

Income before taxes	$	554.8		$	589.5		$	477.1

Gross profit margin		26.8	%		27.4	%		27.9	%

Gross profit margin in 2018 decreased compared to 2017 reflecting the net impact of pricing and raw material inflation and higher employee-related costs, as well as growth investments, partially offset by the benefits from productivity initiatives, including savings from restructuring, net of transition costs.

Gross profit margin in 2017 decreased compared to 2016 due to margin decline in the Industrial and Healthcare Materials reportable segment driven by the impact of acquisitions, growth investments, operational challenges, and a program loss in personal care tapes, which began impacting results in mid-2016.

Marketing, general and administrative expense increased in 2018 compared to 2017 reflecting the impact of acquisitions and other growth investments and the negative impact of changes in foreign currency, partially offset by the benefits from productivity initiatives, including savings from restructuring, net of transition costs.

Marketing, general and administrative expense increased in 2017 compared to 2016 due to acquisitions. Before the impact of acquisitions, the benefits from productivity initiatives, including savings from restructuring, net of transition costs, were partially offset by higher employee-related costs.

(In millions)	2018			2017			2016


Other expense, net by type
Restructuring charges:
Severance and related costs	$	63.0		$	31.2		$	14.7
Asset impairment charges and lease cancellation costs		10.7			2.2			5.2
Other items:
Argentine peso remeasurement transition loss		3.4			–			–
Other restructuring-related charge		.5			–			–
Transaction costs		–			5.2			5.0
Reversal of acquisition-related contingent consideration		(5.0	)		–			–
Net gains on sales of assets		(2.7	)		(2.1	)		(1.1	)

Other expense, net	$	69.9		$	36.5		$	23.8

Refer to Note 13, "Cost Reduction Actions," to the Consolidated Financial Statements for more information.

Management's Discussion and Analysis of
Financial Condition and Results of Operations

Interest expense decreased approximately $4.5 million in 2018 compared to 2017, reflecting the repayment of senior notes in October 2017, which was financed by commercial paper borrowed at a lower interest rate.

Interest expense increased approximately $3 million in 2017 compared to 2016, primarily due to additional long-term debt borrowed in 2017.

We expect our interest expense in 2019 to be higher than in 2018 due to our issuance of $500 million of senior notes in the fourth quarter of 2018.

In the first quarter of 2018, we adopted an accounting guidance update that requires employers with defined benefit plans to present the components of net periodic benefit cost other than service cost, outside of operating income. Refer to Note 1, "Summary of Significant Accounting Policies," to the Consolidated Financial Statements for more information. Other non-operating expense increased in 2018 compared to 2017 due to settlement losses associated with the ADPP and two U.S. nonqualified benefit plans and two of our international benefit plans, partially offset by a higher expected return on plan assets in certain of our international defined benefit pension plans.

Refer to Note 4, "Debt and Capital Leases," in the Consolidated Financial Statements for more information.

The 2018 effective tax rate included measurement period adjustments to our 2017 provisional amount related to the TCJA in accordance with guidance provided under SEC Staff Accounting Bulletin No. 118 ("SAB 118"). In 2018, we adjusted our 2017 provisional amount by recognizing a net tax benefit of $34.7 million. This amount primarily reflected: (i) $39.6 million of tax benefit related to the remeasurement of the net deferred tax asset from cash contributions to the ADPP and realized foreign currency loss, both of which resulted from our decision to accelerate the related deductions on our 2017 U.S. federal income tax return; (ii) $3.6 million of tax charges for changes in our indefinite reinvestment assertions related to our investments in certain foreign subsidiaries after information required to make such determinations was obtained; (iii) $9.5 million of tax charge for adjustments made to the one-time transition tax, primarily due to a change in our filing position and to reflect regulatory and administrative guidance subsequently issued by the Internal Revenue Service and certain state taxing authorities; and (iv) $9.4 million of tax benefit from releasing a previously recorded uncertain tax position after the position was not taken on our 2017 U.S. federal income tax return.

The 2018 effective tax rate also included net tax charges related to: (i) the effects of certain U.S. international tax provisions imposed by the TCJA, including $16 million of tax charge on Global Intangible Low-taxed Income ("GILTI") and $9 million of tax charge on Base Erosion Antiabuse Tax ("BEAT"), partially offset by $2 million of tax benefit on Foreign Derived Intangible Income ("FDII"); (ii) $7.9 million of tax charges for foreign withholding taxes on our current year earnings; (iii) $8.8 million of tax benefit, including previously accrued interest and penalties, primarily from changes in our judgment about tax filing positions due to the effective settlement of our German tax audit for tax years 2006-2010; and (iv) $8 million of tax benefit from decreases in certain tax reserves, including interest and penalties, as a result of closing tax years.

During 2018, after our adoption of the accounting guidance update related to intra-entity transfers of assets other than inventory, certain foreign owned intellectual property was transferred between our foreign subsidiaries. Refer to Note 1, "Summary of Significant Accounting Policies," to the Consolidated Financial Statements for more information. Accordingly, we recognized a net discrete tax benefit of $31 million primarily due to the recognition of a deferred tax asset in a higher tax rate jurisdiction, partially offset by a taxable gain recognized in a lower tax rate jurisdiction.

The 2017 effective tax rate included: (i) $172 million of net tax charge related to the enactment of the TCJA; (ii) $5.1 million of tax benefit from the release of valuation allowance on certain state deferred tax assets; (iii) $4.2 million of tax benefit, including previously accrued interest and penalties, from effective settlements and changes in our judgment about tax filing positions as a result of new information; and (iv) $4.4 million of tax benefit from decreases in certain tax reserves, including interest and penalties, as a result of closing tax years.

The 2016 effective tax rate included: (i) $7.6 million of tax charge associated with the cost to repatriate current earnings of certain foreign subsidiaries; (ii) $46.3 million of tax charge related to U.S. income and foreign withholding taxes resulting from changes in indefinite reinvestment assertions on certain foreign earnings and profits; (iii) $16.8 million of tax benefit resulting from settlements of certain foreign audits; (iv) $5.4 million of tax benefit resulting from expirations of statutes of limitations; (v) $6.7 million of tax benefit from the release of valuation allowances against certain deferred tax assets in a foreign jurisdiction associated with a structural simplification approved by the tax authority; (vi) $3.6 million of tax benefit from the release of valuation allowances on certain state deferred tax assets; and (vii) $8.4 million of tax charge from deferred tax adjustments resulting from tax rate changes in certain foreign jurisdictions.

Refer to Note 14, "Taxes Based on Income," to the Consolidated Financial Statements for more information.

Management's Discussion and Analysis of
Financial Condition and Results of Operations

In 2018, net sales increased on an organic basis due to higher volume and pricing actions. Net sales increased on an organic basis at mid-single digit rates in emerging markets and North America and at a low-single digit rate in Western Europe.

In 2017, net sales increased on an organic basis due to higher volume. Net sales increased on an organic basis at mid-single digit rates in emerging markets and Western Europe and at a low-single digit rate in North America.

Operating income decreased in 2018 compared to 2017 reflecting higher restructuring charges, employee-related costs and the net impact of pricing and raw material costs, excluding the effects of foreign currency, partially offset by the combined effect of volume and mix, as well as a net benefit from changes in foreign currency.

Operating income increased in 2017 compared to 2016 primarily reflecting higher volume/mix and benefits from productivity initiatives, including savings from restructuring, net of transition costs, partially offset by higher employee-related costs and the net impact of pricing and raw material costs.

In 2018, net sales increased on an organic basis driven by strength in both radio-frequency identification solutions and the base business.

In 2017, net sales increased on an organic basis due to higher volume, reflecting growth in both the base business and radio-frequency identification solutions.

Operating income increased in 2018 compared to 2017 reflecting higher volume, the benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and lower amortization of other intangibles resulting from business acquisitions, partially offset by higher employee-related costs and growth investments.

Operating income increased in 2017 compared to 2016 due to the benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and higher volume, partially offset by higher employee-related costs.

Management's Discussion and Analysis of Financial Condition and Results of Operations

In 2018, net sales increased on an organic basis primarily due to higher volume in industrial categories.

In 2017, net sales increased on an organic basis due to higher volume, as growth in industrial categories more than offset the anticipated decline in healthcare categories.

Operating income increased in 2018 compared to 2017 driven by the net impact of acquisitions and organic growth, partially offset by growth investments.

Operating income decreased in 2017 compared to 2016 due to a program loss in personal care tapes, which began impacting results in mid-2016, higher employee-related costs, and growth investments, partially offset by volume growth in the industrial categories and the impact of acquisitions.

(In millions)	2018			2017			2016


Net income	$	467.4		$	281.8		$	320.7
Depreciation and amortization		181.0			178.7			180.1
Provision for doubtful accounts and sales returns		45.6			37.6			54.4
Net losses (gains) from impairments, sale of assets and investment settlements		6.8			(.4	)		(.6	)
Stock-based compensation		34.3			30.2			27.2
Losses from settlements of pension obligations		93.7			–			41.4
Deferred income taxes and other non-cash taxes		(32.7	)		151.6			52.3
Other non-cash expense and loss		53.6			53.9			46.2
Trade accounts receivable		(62.5	)		(141.2	)		(88.2	)
Inventories		(70.5	)		(14.9	)		(19.6	)
Other current assets		(5.6	)		(7.9	)		(7.6	)
Accounts payable		43.6			83.4			31.6
Accrued liabilities		(29.8	)		(.6	)		32.4
Taxes on income		(35.5	)		29.6			(14.1	)
Other assets		(6.0	)		(13.0	)		(2.3	)
Long-term retirement benefits and other liabilities		(225.5	)		(23.1	)		(71.8	)

Net cash provided by operating activities	$	457.9		$	645.7		$	582.1

For cash flow purposes, changes in assets and liabilities and other adjustments exclude the impact of foreign currency translation (discussed below in "Analysis of Selected Balance Sheet Accounts").

In 2018, cash flow provided by operating activities decreased compared to 2017 primarily due to our $200 million contribution to the ADPP in connection with its termination, higher income tax payments, net of refunds, changes in operational working capital, and higher incentive compensation payments, partially offset by higher net income.

In 2017, cash flow provided by operating activities increased compared to 2016 primarily due to higher income before taxes, as well as lower pension plan contributions, partially offset by higher income tax payments, net of refunds. In addition, operating activities reflected the impact of our adoption of the accounting guidance update related to stock-based payments described in Note 1, "Summary of Significant Accounting Policies," to the Consolidated Financial Statements.

In 2018, we invested in equipment to support growth primarily in Asia, North America and Europe and to improve manufacturing productivity. In 2017 and 2016, we invested in new equipment to support growth in Asia, Europe and North America and to improve manufacturing productivity.

In 2018, we invested in information technology primarily associated with enterprise resource planning system implementations in North America and Asia. In 2017, we invested in information technology primarily associated with enterprise resource planning system implementations in North America, Asia, and Europe. Information technology investments in 2016 were primarily associated with standardization initiatives in Asia and North America.

In 2018, proceeds from insurance were associated with our corporate-owned life insurance policies. We also had higher proceeds from net sales of investments in 2018.

In 2018, we paid $3.8 million for investments in unconsolidated businesses. In 2017 and 2016, the aggregate payments for acquisitions, net of cash acquired, and investments in businesses were approximately $319 million and $237 million, respectively, which we

Management's Discussion and Analysis of Financial Condition and Results of Operations

funded through cash and commercial paper borrowings. The 2017 Acquisitions were also partially funded through proceeds from the senior notes we issued in 2017.

Refer to Note 2, "Acquisitions," to the Consolidated Financial Statements for more information.

In December 2018, we issued $500 million of senior notes, due December 2028. The senior notes bear an interest rate of 4.875% per year, payable semi-annually in arrears. The net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses, were $493.3 million, which we used to repay commercial paper borrowings. Prior to the issuance of these senior notes, we used commercial paper borrowings in the third quarter to fund our $200 million contribution to the ADPP in connection with its termination.

In March 2017, we issued €500 million of senior notes, due March 2025. The senior notes bear an interest rate of 1.25% per year, payable annually in arrears. The net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses, were $526.6 million (€495.5 million), a portion of which we used to repay commercial paper borrowed to finance a portion of the purchase price for our acquisition of the European business of Mactac and the remainder of which we used for general corporate purposes, including other acquisitions.

In March 2016, we entered into an agreement to establish a Euro-Commercial Paper Program pursuant to which we may issue unsecured commercial paper notes up to a maximum aggregate amount outstanding of $500 million. Borrowings from this program were used to fund a portion of the purchase price for our acquisition of the European business of Mactac in 2016.

Given the seasonality of our cash flow from operating activities, during 2018, 2017, and 2016, our commercial paper borrowings were used to fund share repurchase activity, dividend payments, and capital expenditures, and for other general corporate purposes.

Refer to Note 2, "Acquisitions," and Note 4, "Debt and Capital Leases," to the Consolidated Financial Statements for more information.

We paid dividends of $2.01 per share in 2018 compared to $1.76 per share in 2017. In April 2018, we increased our quarterly dividend to $.52 per share, representing an increase of approximately 16% from our previous dividend rate of $.45 per share.

From time to time, our Board authorizes the repurchase of shares of our outstanding common stock. Repurchased shares may be reissued under our long-term incentive plan or used for other corporate purposes. In 2018, we repurchased approximately 4 million shares of our common stock at an aggregate cost of $392.9 million. In 2017, we repurchased approximately 1.5 million shares of our common stock at an aggregate cost of $129.7 million.

In April 2017, our Board authorized the repurchase of additional shares of our common stock with a fair market value of up to $650 million, exclusive of any fees, commissions or other expenses related to such purchases, in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased. As of December 29, 2018, shares of our common stock in the aggregate amount of $232.4 million remained authorized for repurchase under this Board authorization.

In 2018, tax withholding for stock-based compensation increased compared to 2017 as a result of higher vesting-date share prices for equity awards vested during the year. In 2017, tax withholding for stock-based compensation, reflected the impact of our adoption of the accounting guidance update related to stock-based payments.

The number of stock options exercised was approximately .03 million, .6 million, and 1.4 million in 2018, 2017, and 2016, respectively. Refer to Note 12, "Long-Term Incentive Compensation," to the Consolidated Financial Statements for more information.

Property, plant and equipment, net, increased by approximately $40 million to $1.1 billion at year-end 2018, which primarily reflected purchases of property, plant and equipment and the impact of foreign currency translation, partially offset by depreciation expense.

Goodwill decreased by approximately $43 million to $941.8 million at year-end 2018 due to purchase price adjustments related to the acquisition of Yongle Tape and the impact of foreign currency translation.

Other intangibles resulting from business acquisitions, net, decreased by approximately $22 million to $144 million at year-end 2018, which primarily reflected amortization expense.

Refer to Note 3, "Goodwill and Other Intangibles Resulting from Business Acquisitions," to the Consolidated Financial Statements for more information.

Long-term retirement benefits and other liabilities decreased by approximately $295 million to $334.7 million, primarily reflecting our pension plan contribution and the reclassification of the remaining obligations to other current liabilities as a result of the termination of the ADPP, a reduction in contingent consideration liabilities, and lower net obligation for our international pension plans as a result of higher returns on plan assets and discount rates.

Management's Discussion and Analysis of Financial Condition and Results of Operations

The balance of our shareholders' equity decreased by approximately $91 million to $955 million at year-end 2018, which reflected share repurchases, dividend payments and foreign currency translation, partially offset by current year net income, the net decrease in "accumulated other comprehensive loss," and the use of treasury shares to settle the exercise of stock options and vesting of stock-based awards, as well as to fund contributions to our U.S. defined contribution plan.

Refer to Note 6, "Pension and Other Postretirement Benefits," and Note 11, "Supplemental Equity and Comprehensive Income Information," to the Consolidated Financial Statements for more information.

In 2018, international operations generated approximately 77% of our net sales. Our future results are subject to changes in political and economic conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.

The favorable impact of foreign currency translation on net sales in 2018 compared to 2017 was primarily related to euro-denominated sales and sales in China, partially offset by the unfavorable impact of foreign currency translation on sales in Brazil and Turkey.

On July 1, 2018, we began accounting for our operations in Argentina as highly inflationary, as the country's three-year cumulative inflation rate exceeded 100%. As a result, the functional currency of our Argentine subsidiary became the U.S. dollar.

The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate. We also utilize certain foreign-currency-denominated debt to mitigate our foreign currency translation exposure from our net investment in foreign operations.

We utilize the financial ratios discussed below to assess our financial condition and operating performance.

Operational working capital, as a percentage of annualized current-quarter net sales, is reconciled to working capital below. Our objective is to minimize our investment in operational working capital, as a percentage of annualized current-quarter net sales, to maximize our cash flow and return on investment. Operational working capital, as a percentage of annualized current-quarter net sales in 2018 was comparable to 2017.

(In millions, except percentages)	2018			2017


(A) Working capital	$	304.0		$	266.1
Reconciling items:
Cash and cash equivalents		(232.0	)		(224.4	)
Current refundable income taxes and other current assets		(221.3	)		(217.3	)
Assets held for sale		(3.6	)		(6.3	)
Short-term borrowings and current portion of long-term debt and capital leases		194.6			265.4
Current income taxes payable and other current accrued liabilities		768.9			699.2

(B) Operational working capital	$	810.6		$	782.7

(C) Fourth-quarter net sales, annualized	$	7,074.8		$	6,941.2

Operational working capital, as a percentage of annualized current-quarter net sales (B) ÷ (C)		11.5	%		11.3	%

The average number of days sales outstanding was 62 days in 2018 compared to 63 days in 2017, calculated using the four-quarter average accounts receivable balance divided by the average daily sales in 2018 and 2017, respectively. The decrease in the average number of days sales outstanding primarily reflected the impact of foreign currency translation.

Average inventory turnover was 7.8 in 2018 compared to 7.9 in 2017, calculated using the annual cost of sales in 2018 and 2017, respectively, and divided by the four-quarter average inventory balance. The decrease in the average inventory turnover primarily reflected the timing of inventory purchases.

The average number of days payable outstanding was 73 days in 2018 compared to 72 days in 2017, calculated using the four-quarter average accounts payable balance divided by the average daily cost of products sold in 2018 and 2017, respectively. The increase in average number of days payable outstanding primarily reflected the timing of vendor payments, partially offset by the impact of the 2017 Acquisitions and foreign currency translation.

Our revolving credit facility (the "Revolver") contains financial covenants requiring that we maintain specified ratios of total debt and interest expense in relation to certain measures of income. As of December 29, 2018 and December 30, 2017, we were in compliance with our financial covenants.

The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities on notes with similar rates, credit rating, and remaining maturities. The fair value of short-term borrowings, which includes commercial paper issuances and short-term lines of credit, approximates carrying value given the short duration of these obligations. The increase in the fair value of our total debt from $1.6 billion at December 30, 2017 to $2 billion at

Management's Discussion and Analysis of Financial Condition and Results of Operations

December 29, 2018 primarily reflected our issuance of $500 million of senior notes in 2018. Fair value amounts were determined based primarily on Level 2 inputs, which are inputs other than quoted prices in active markets that are either directly or indirectly observable. Refer to Note 1, "Summary of Significant Accounting Policies," to the Consolidated Financial Statements for more information.

Capital resources include cash flows from operations, cash and cash equivalents and debt financing, including ready access to commercial paper. We plan to use these resources to fund operational needs, including payments related to the ADPP termination and cost reduction actions.

At year-end 2018, we had cash and cash equivalents of $232 million held in accounts at third-party financial institutions. Our cash balances are held in numerous locations throughout the world. At year-end 2018, the majority of our cash and cash equivalents was held by our foreign subsidiaries.

To meet U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating foreign earnings and profits. However, if we were to repatriate incremental foreign earnings and profits, we may be subject to withholding taxes imposed by foreign tax authorities and additional U.S. taxes due to the impact of foreign currency movements related to such earnings and profits.

In November 2017, we amended and restated the Revolver, increasing the amount available from certain domestic and foreign banks from $700 million to $800 million. The amendment also extended the Revolver's maturity date to November 8, 2022. The maturity date may be extended for additional one-year periods under certain circumstances. The commitments under the Revolver may be increased by up to $300 million, subject to lender approvals and customary requirements. The Revolver is used as a back-up facility for our commercial paper program and can be used for other corporate purposes.

No balances were outstanding under the Revolver as of year-end 2018 or 2017. Commitment fees associated with the Revolver in 2018, 2017, and 2016 were $1.2 million, $1.1 million, and $1.1 million, respectively.

In addition to the Revolver, we have significant short-term lines of credit available in various countries totaling approximately $330 million at December 29, 2018. These lines may be cancelled at any time by us or the issuing banks. Short-term borrowings outstanding under our lines of credit were $45.5 million and $76.1 million at December 29, 2018 and December 30, 2017, respectively, with a weighted-average interest rate of 7% and 6.2%, respectively.

In March 2016, we entered into an agreement to establish a Euro-Commercial Paper Program pursuant to which we may issue unsecured commercial paper notes up to a maximum aggregate amount outstanding of $500 million. Proceeds from issuances under this program may be used for general corporate purposes. The maturities of the notes may vary, but may not exceed 364 days from the date of issuance. Our payment obligations with respect to any notes issued under this program are backed by the Revolver. There are no financial covenants under this program. As of December 29, 2018, no balance was outstanding under this program.

We had $131 million and $183.8 million of U.S. commercial paper borrowings outstanding at year-end 2018 and 2017, respectively, with a weighted-average interest rate of 2.75% and 1.79%, respectively.

Refer to Note 4, "Debt and Capital Leases," to the Consolidated Financial Statements for more information.

We are exposed to financial market risk resulting from changes in interest and foreign currency rates, and to possible liquidity and credit risks of our counterparties.

Our total debt increased by approximately $385 million to $1.97 billion at year-end 2018 compared to $1.58 billion at year-end 2017, primarily reflecting our issuance of $500 million of senior notes, a portion of which we used to repay commercial paper borrowings.

Credit ratings are a significant factor in our ability to raise short- and long-term financing. The credit ratings assigned to us also impact the interest rates paid and our access to commercial paper, credit facilities, and other borrowings. A downgrade of our short-term credit ratings could impact our ability to access the commercial paper markets. If our access to commercial paper markets were to become limited, the Revolver and our other credit facilities would be available to meet our short-term funding requirements, if necessary. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to maintaining an investment grade rating.

Management's Discussion and Analysis of Financial Condition and Results of Operations

We enter into operating leases primarily for office and warehouse space and equipment for information technology, machinery, and transportation. The table above includes minimum annual rental commitments on operating leases having initial or remaining non-cancelable lease terms of one year or more.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions for the reporting period and as of the financial statement date. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenue and expense. Actual results could differ from these estimates.

Critical accounting estimates are those that are important to our financial condition and results, and which require us to make difficult, subjective and/or complex judgments. Critical accounting estimates cover accounting matters that are inherently uncertain because their future resolution is unknown. We believe our critical accounting estimates include accounting for goodwill, pension and postretirement benefits, taxes based on income, and long-term incentive compensation.

Our reporting units are composed of either a discrete business or an aggregation of businesses with similar economic characteristics. In performing the required impairment tests, we have the option to first assess qualitative factors before performing a quantitative assessment for goodwill impairment. If the qualitative assessment indicates that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value, a quantitative assessment is performed. A quantitative assessment primarily consists of a present value (discounted cash flow) method to determine the fair value of the reporting units with goodwill. For certain reporting units the goodwill of which is acquired in the current period, we perform a qualitative assessment to determine whether a quantitative assessment is necessary. We perform our annual impairment test of goodwill during the fourth quarter.

Certain factors may result in the need to perform an impairment test prior to the fourth quarter, including significant underperformance of a business relative to expected operating results, significant adverse economic and industry trends, significant decline in our market capitalization for an extended period of time relative to net book value, or a decision to divest a portion of a reporting unit.

We compare the fair value of each reporting unit to its carrying amount, and, to the extent the carrying amount exceeds the fair value, an impairment of goodwill is recognized for the excess up to the amount of goodwill of that reporting unit.

Management's Discussion and Analysis of Financial Condition and Results of Operations

long-term business plan period. We base our fair value estimates on projected financial information and assumptions that we believe are reasonable. However, actual future results may materially differ from these estimates and projections. The valuation methodology used to estimate the fair value of reporting units requires inputs and assumptions that reflect current market conditions, as well as the impact of planned business and operational strategies that require management judgment. The estimated fair value could increase or decrease depending on changes in the inputs and assumptions.

In our annual impairment analysis in the fourth quarter of 2018, the goodwill of reporting units in our Label and Graphic Materials and Retail Branding and Information Solutions reportable segments were tested utilizing a qualitative assessment. Based on this assessment we determined that the fair values of the reporting units in both reportable segments were greater than their carrying values. Therefore, the goodwill in these reporting units was not impaired.

Additionally, in our annual impairment analysis, the goodwill of reporting units in our Industrial and Healthcare Materials reportable segment were tested utilizing a quantitative assessment. This assessment indicated that the fair values of these reporting units exceeded their respective carrying amounts, including goodwill. Except for our Yongle Tape reporting unit acquired in 2017, the fair values of these reporting units exceeded their carrying amounts by 100% or more. Yongle Tape's fair value exceeded its carrying value by 22%, assuming a discount rate of 12% and a perpetual growth rate of 3.5%. As of December 29, 2018, the carrying value of Yongle Tape's goodwill was $81.7 million.

Assumptions used in determining projected benefit obligations and the fair value of plan assets for our defined benefit pension plans and other postretirement benefit plans are evaluated by management in consultation with outside actuaries. In the event that we determine that changes are warranted in the assumptions used, such as the discount rate, expected long-term rate of return, or health care costs, future pension and postretirement benefit expenses could increase or decrease. Due to changes in market conditions or participant population, the actuarial assumptions that we use may differ from actual results, which could have a significant impact on our pension and postretirement liability and related costs.

In consultation with our actuaries, we annually review and determine the discount rates to be used in valuing our postretirement obligations. With the exception of the ADPP, the assumed discount rate for each pension plan reflects market rates for high quality corporate bonds currently available. Our discount rate is determined by evaluating yield curves consisting of large populations of high quality corporate bonds. The projected pension benefit payment streams are then matched with the bond portfolios to determine a rate that reflects the liability duration unique to our plans. As of December 29, 2018, the discount rate for the ADPP after reflecting plan termination was set based on estimated insurer pricing. As of December 29, 2018, a .25% increase in the discount rate in the U.S. would have decreased our year-end projected benefit obligation by approximately $23 million and increased expected periodic benefit cost for the coming year by approximately $.04 million. Conversely, a .25% decrease in the discount rate in the U.S. would have increased our year-end projected benefit obligation by approximately $24 million and decreased expected periodic benefit cost for the coming year by approximately $.1 million. As of December 29, 2018, a .25% increase in the discount rate associated with our international plans would have decreased our year-end projected benefit obligation by $34 million and increased expected periodic benefit cost for the coming year by approximately $2 million. Conversely, a .25% decrease in the discount rate associated with our international plans would have increased our year-end projected benefit obligation by approximately $37 million and decreased expected periodic benefit cost for the coming year by approximately $2 million.

We use the full yield curve approach to estimate the service and interest cost components of net periodic benefit cost for our pension and other postretirement benefit plans. Under this approach, we applied multiple discount rates from a yield curve composed of the rates of return on several hundred high-quality, fixed income corporate bonds available at the measurement date. We believe this approach provides a more precise measurement of service and interest cost by aligning the timing of the plans' liability cash flows to the corresponding rates on the yield curve.

We determine the long-term rate of return assumption for plan assets by reviewing the historical and expected returns of both the equity and fixed income markets, taking into account our asset allocation, the correlation between returns in our asset classes, and our mix of active and passive investments. Additionally, current market conditions, including interest rates, are evaluated and market data is reviewed for reasonableness and appropriateness. An increase or decrease of .25% on the long-term return on assets in the U.S. would have decreased or increased, respectively, our periodic benefit cost for the coming year by approximately $.5 million. An increase or decrease of .25% on the long-term return on assets associated with our international plans would have decreased or increased, respectively, our periodic benefit cost for the coming year by approximately $2 million.

Deferred income tax assets represent amounts available to reduce income taxes payable in future years. These assets arise because of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as from net operating losses and tax credit carryforwards. These amounts are adjusted, as appropriate, to reflect changes in tax rates expected to be in effect when the temporary differences reverse. We evaluate the recoverability of these future tax deductions and credits by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. Our assessment of these sources of income relies heavily on estimates. Our forecasted earnings by jurisdiction are determined by the manner in which we operate our business and any changes to our operations may affect our effective tax rate. For example, our future income tax rate could be adversely affected by earnings being lower than anticipated in jurisdictions in which we have significant deferred tax assets that are dependent on such earnings to be realized. We use historical experience along with operating forecasts to evaluate expected future taxable income. To the extent we do not consider it more likely than not that a deferred tax asset will be recovered, a

Management's Discussion and Analysis of Financial Condition and Results of Operations

valuation allowance is established in the period we make such a determination. A tax planning strategy is defined as "an action that: is prudent and feasible; an enterprise ordinarily might not take, but would take to prevent an operating loss or tax credit carryforward from expiring unused; and would result in realization of deferred tax assets."

Our income tax rate is significantly affected by the different tax rates applicable in the jurisdictions in which we do business. For example, the TCJA had a significant impact on our effective tax rate for the fourth quarter of 2017.

We calculate our current and deferred tax provision based on estimates and assumptions that could differ from the actual results reflected in income tax returns filed in subsequent years. Adjustments based on filed returns are recorded when identified.

Tax laws are complex and subject to different interpretations by taxpayers and governmental taxing authorities. We review our tax positions quarterly and adjust the balances as new information becomes available. Significant judgment is required in determining our tax expense and evaluating our tax positions, including evaluating uncertainties. Our estimate of the potential outcome of any uncertain tax issue is subject to management's assessment of relevant facts and circumstances existing at the balance sheet date, taking into consideration existing laws, regulations and practices of any governmental authorities exercising jurisdiction over our operations. For example, the European Commission has conducted investigations in multiple countries focusing on whether local country tax rulings or tax legislation provides preferential tax treatment that violates European Union state aid rules and concluded that certain countries, including the Netherlands, Luxembourg, Belgium, and Ireland, have provided illegal state aid in certain cases. We continue to monitor state aid developments since they involve jurisdictions in which we have significant operations, and consider these matters in determining our uncertain tax positions.

Our income tax provision for fiscal year 2018 included measurement period adjustments to our 2017 provisional amount related to the TCJA in accordance with guidance provided under SAB 118. We completed our analysis based on our interpretation of available U.S. Treasury regulations and administrative interpretations. However, the provisions of the TCJA are subject to further amendments, interpretations, regulations, and court cases, any of which could increase or decrease one or more impacts of the legislation.

Refer to Note 14, "Taxes Based on Income," to the Consolidated Financial Statements for more information.

We have not capitalized expense associated with our long-term incentive compensation.

Changes in estimated forfeiture rates are recorded as cumulative adjustments in the period estimates are revised.

Our stock-based compensation expense is based on the fair value of awards, adjusted for estimated forfeitures, and amortized on a straight-line basis over the requisite service period for stock options, restricted stock units ("RSUs"), and performance units ("PUs"). The compensation expense related to market-leveraged stock units ("MSUs") is based on the fair value of awards, adjusted for estimated forfeitures, and amortized on a graded-vesting basis over their respective performance periods.

Compensation expense for awards with a market condition as a performance objective, which includes PUs and MSUs, is not adjusted if the condition is not met, as long as the requisite service period is met.

The fair value of stock options is estimated as of the date of grant using the Black-Scholes option-pricing model. This model requires input assumptions for our expected dividend yield, expected stock price volatility, risk-free interest rate and the expected option term.

The following assumptions are used in estimating the fair value of granted stock options:

Risk-free interest rate is based on the 52-week average of the Treasury-Bond rate that has a term corresponding to the expected option term.

Expected stock price volatility represents an average of implied and historical volatility.

Expected dividend yield is based on the current annual dividend divided by the 12-month average of our monthly stock price prior to the date of grant.

Expected option term is determined based on historical experience under our stock option and incentive plans.

The fair value of RSUs and the component of PUs that is subject to achievement of performance objectives based on a financial performance condition is determined based on the fair market value of our common stock as of the date of grant, adjusted for foregone dividends.

The fair value of stock-based awards that are subject to achievement of performance objectives based on a market condition, which includes MSUs and the other component of PUs, is determined using the Monte-Carlo simulation model, which utilizes multiple input variables, including expected stock price volatility and other assumptions appropriate for determining fair value, to estimate the probability of satisfying the target performance objectives established for the award.

Certain of these assumptions are based on management's estimates, in consultation with outside specialists. Significant changes in assumptions for future awards and actual forfeiture rates could materially impact stock-based compensation expense and our results of operations.

Cash-based awards consist of long-term incentive units ("LTI Units") granted to eligible employees. LTI Units are classified as liability awards and remeasured at each quarter-end over the applicable vesting or performance period. In addition to LTI Units with terms and conditions that mirror those of RSUs, we also grant certain employees LTI Units with terms and conditions that mirror those of PUs and MSUs.

Refer to Note 1, "Summary of Significant Accounting Policies," to the Consolidated Financial Statements for this information.

We are exposed to the impact of changes in interest rates and foreign currency exchange rates.

We generally do not purchase or hold foreign currency or interest rate or commodity contracts for trading purposes.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Our objective in managing our exposure to foreign currency changes is to reduce the risk to our earnings and cash flow associated with foreign exchange rate changes. As a result, we enter into foreign exchange forward, option and swap contracts to reduce risks associated with the value of our existing foreign currency assets, liabilities, firm commitments and anticipated foreign revenues and costs, when available and appropriate. The gains and losses on these contracts are intended to offset changes in the related exposures. We do not hedge our foreign currency translation exposure in a manner that would entirely eliminate the effects of changes in foreign exchange rates on our net income. We also utilize certain foreign-currency-denominated debt to mitigate our foreign currency translation exposure from our net investment in foreign operations.

Our objective in managing our exposure to interest rate changes is to reduce the impact of interest rate changes on earnings and cash flows. To achieve our objectives, we may periodically use interest rate contracts to manage our exposure to interest rate changes.

Additionally, we enter into certain natural gas futures contracts to reduce the risks associated with natural gas anticipated to be used in manufacturing and operations. These amounts are not material to our financial statements.

In the normal course of operations, we also face other risks that are either non-financial or non-quantifiable. These risks principally include changes in economic or political conditions, other risks associated with foreign operations, commodity price risk and litigation and compliance risk, which are not reflected in the analyses that follow.

We use a Value-At-Risk ("VAR") model to determine the estimated maximum potential one-day loss in earnings associated with our foreign exchange positions and contracts. This approach assumes that market rates or prices for foreign exchange positions and contracts are normally distributed. VAR model estimates were made assuming normal market conditions. The model includes foreign exchange derivative contracts. Forecasted transactions, firm commitments, and accounts receivable and accounts payable denominated in foreign currencies, which certain of these instruments are intended to hedge, were excluded from the model.

In both 2018 and 2017, the VAR was estimated using a variance-covariance methodology. The currency correlation was based on one-year historical data obtained from one of our domestic banks. A 95% confidence level was used for a one-day time horizon.

The estimated maximum potential one-day loss in earnings for our foreign exchange positions and contracts was $.5 million at year-end 2018 and $1.1 million at year-end 2017.

The VAR model is a risk analysis tool and does not represent actual losses in fair value that we could incur, nor does it consider the potential effect of favorable changes in market factors.

In 2018, an assumed 30 basis point move in interest rates affecting our variable-rate borrowings (10% of our weighted-average interest rate on floating rate debt) would have increased interest expense by approximately $1.3 million.

In 2017, an assumed 30 basis point move in interest rates affecting our variable-rate borrowings (10% of our weighted-average interest rate on floating rate debt) would have increased interest expense by approximately $.7 million.

(Dollars in millions, except per share amount)	December 29, 2018			December 30, 2017


Assets
Current assets:
Cash and cash equivalents	$	232.0		$	224.4
Trade accounts receivable, less allowances of $21.1 and $36.2 at year-end 2018 and 2017, respectively		1,189.7			1,180.3
Inventories, net		651.4			609.6
Refundable income taxes		27.0			28.9
Assets held for sale		3.6			6.3
Other current assets		194.3			188.4

Total current assets		2,298.0			2,237.9
Property, plant and equipment, net		1,137.4			1,097.9
Goodwill		941.8			985.1
Other intangibles resulting from business acquisitions, net		144.0			166.3
Non-current deferred income taxes		205.3			196.3
Other assets		451.0			453.4

	$	5,177.5		$	5,136.9

Liabilities and Shareholders' Equity
Current liabilities:
Short-term borrowings and current portion of long-term debt and capital leases	$	194.6		$	265.4
Accounts payable		1,030.5			1,007.2
Accrued payroll and employee benefits		217.9			248.5
Accrued trade rebates		129.8			112.3
Income taxes payable		58.1			49.2
Other accrued liabilities		363.1			289.2

Total current liabilities		1,994.0			1,971.8
Long-term debt and capital leases		1,771.6			1,316.3
Long-term retirement benefits and other liabilities		334.7			629.3
Non-current deferred and payable income taxes		122.1			173.3
Commitments and contingencies (see Notes 7 and 8)
Shareholders' equity:
Common stock, $1 par value per share, authorized – 400,000,000 shares at year-end 2018 and 2017; issued – 124,126,624 shares at year-end 2018 and 2017; outstanding – 84,723,655 shares and 88,011,541 shares at year-end 2018 and 2017, respectively		124.1			124.1
Capital in excess of par value		872.0			862.6
Retained earnings		2,864.9			2,596.7
Treasury stock at cost, 39,402,969 shares and 36,115,083 shares at year-end 2018 and 2017, respectively		(2,223.9	)		(1,856.7	)
Accumulated other comprehensive loss		(682.0	)		(680.5	)

Total shareholders' equity		955.1			1,046.2

	$	5,177.5		$	5,136.9

(In millions, except per share amounts)	2018			2017		2016


Net sales	$	7,159.0		$	6,613.8	$	6,086.5
Cost of products sold		5,243.5			4,801.6		4,386.8

Gross profit		1,915.5			1,812.2		1,699.7
Marketing, general and administrative expense		1,127.5			1,105.2		1,085.7
Other expense, net		69.9			36.5		23.8
Interest expense		58.5			63.0		59.9
Other non-operating expense		104.8			18.0		53.2

Income before taxes		554.8			589.5		477.1
Provision for income taxes		85.4			307.7		156.4
Equity method investment net losses		(2.0	)		–		–

Net income	$	467.4		$	281.8	$	320.7

Per share amounts:
Net income per common share	$	5.35		$	3.19	$	3.60

Net income per common share, assuming dilution	$	5.28		$	3.13	$	3.54

Weighted average number of shares outstanding:
Common shares		87.3			88.3		89.1
Common shares, assuming dilution		88.6			90.1		90.7

(In millions)	2018			2017			2016


Net income	$	467.4		$	281.8		$	320.7
Other comprehensive (loss) income, net of tax:
Foreign currency translation:
Translation (loss) gain		(91.2	)		56.4			(53.7	)
Pension and other postretirement benefits:
Net loss recognized from actuarial gain/loss and prior service cost/credit		(4.1	)		(3.0	)		(62.9	)
Reclassifications to net income		93.8			19.3			44.2
Cash flow hedges:
Gains (losses) recognized on cash flow hedges		1.1			(2.2	)		.7
Reclassifications to net income		(1.1	)		.9			2.8

Other comprehensive (loss) income, net of tax		(1.5	)		71.4			(68.9	)

Total comprehensive income, net of tax	$	465.9		$	353.2		$	251.8

(Dollars in millions, except per share amounts)	Common stock, $1 par value		Capital in excess of par value		Retained earnings			Treasury stock			Accumulated other comprehensive loss			Total


Balance as of January 2, 2016	$	124.1	$	834.0	$	2,277.6		$	(1,587.0	)	$	(683.0	)	$	965.7
Net income		–		–		320.7			–			–			320.7
Other comprehensive loss, net of tax		–		–		–			–			(68.9	)		(68.9	)
Repurchase of 3,781,528 shares for treasury		–		–		–			(262.4	)		–			(262.4	)
Issuance of 1,842,165 shares under stock-based compensation plans, including tax of $12.3		–		18.0		7.7			67.2			–			92.9
Contribution of 280,526 shares to 401(k) Plan		–		–		9.8			10.2			–			20.0
Dividends: $1.60 per share		–		–		(142.5	)		–			–			(142.5	)

Balance as of December 31, 2016	$	124.1	$	852.0	$	2,473.3		$	(1,772.0	)	$	(751.9	)	$	925.5
Net income		–		–		281.8			–			–			281.8
Other comprehensive income, net of tax		–		–		–			–			71.4			71.4
Repurchase of 1,488,890 shares for treasury		–		–		–			(129.7	)		–			(129.7	)
Issuance of 960,656 shares under stock-based compensation plans		–		10.6		(14.4	)		36.2			–			32.4
Contribution of 230,915 shares to 401(k) Plan		–		–		11.5			8.8			–			20.3
Dividends: $1.76 per share		–		–		(155.5	)		–			–			(155.5	)

Balance as of December 30, 2017	$	124.1	$	862.6	$	2,596.7		$	(1,856.7	)	$	(680.5	)	$	1,046.2
Tax accounting for intra-entity asset transfers(1)		–		–		(13.8	)		–			–			(13.8	)

Balance as of December 31, 2017	$	124.1	$	862.6	$	2,582.9		$	(1,856.7	)	$	(680.5	)	$	1,032.4
Net income		–		–		467.4			–			–			467.4
Other comprehensive loss, net of tax		–		–		–			–			(1.5	)		(1.5	)
Repurchase of 3,951,215 shares for treasury		–		–		–			(392.9	)		–			(392.9	)
Issuance of 458,506 shares under stock-based compensation plans		–		9.4		(24.1	)		17.6			–			2.9
Contribution of 204,823 shares to 401(k) Plan		–		–		13.7			8.1			–			21.8
Dividends: $2.01 per share		–		–		(175.0	)		–			–			(175.0	)

Balance as of December 29, 2018	$	124.1	$	872.0	$	2,864.9		$	(2,223.9	)	$	(682.0	)	$	955.1

(In millions)	2018			2017			2016


Operating Activities
Net income	$	467.4		$	281.8		$	320.7
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		141.5			126.6			117.5
Amortization		39.5			52.1			62.6
Provision for doubtful accounts and sales returns		45.6			37.6			54.4
Net losses (gains) from impairments, sale of assets and investment settlements		6.8			(.4	)		(.6	)
Stock-based compensation		34.3			30.2			27.2
Losses from settlements of pension obligations		93.7			–			41.4
Deferred income taxes and other non-cash taxes		(32.7	)		151.6			52.3
Other non-cash expense and loss		53.6			53.9			46.2
Changes in assets and liabilities and other adjustments:
Trade accounts receivable		(62.5	)		(141.2	)		(88.2	)
Inventories		(70.5	)		(14.9	)		(19.6	)
Other current assets		(5.6	)		(7.9	)		(7.6	)
Accounts payable		43.6			83.4			31.6
Accrued liabilities		(29.8	)		(.6	)		32.4
Taxes on income		(35.5	)		29.6			(14.1	)
Other assets		(6.0	)		(13.0	)		(2.3	)
Long-term retirement benefits and other liabilities		(225.5	)		(23.1	)		(71.8	)

Net cash provided by operating activities		457.9			645.7			582.1

Investing Activities
Purchases of property, plant and equipment		(226.7	)		(190.5	)		(176.9	)
Purchases of software and other deferred charges		(29.9	)		(35.6	)		(29.7	)
Proceeds from sales of property, plant and equipment		9.4			6.0			8.5
Proceeds from insurance and sales (purchases) of investments, net		18.5			(3.9	)		3.1
Payments for acquisitions, net of cash acquired, and investments in businesses		(3.8	)		(319.3	)		(237.2	)

Net cash used in investing activities		(232.5	)		(543.3	)		(432.2	)

Financing Activities
Net (decrease) increase in borrowings (maturities of three months or less)		(77.6	)		(89.2	)		234.9
Additional long-term borrowings		493.3			542.9			–
Repayments of long-term debt and capital leases		(6.4	)		(253.8	)		(2.7	)
Dividends paid		(175.0	)		(155.5	)		(142.5	)
Share repurchases		(392.9	)		(129.7	)		(262.4	)
Net (tax withholding) proceeds related to stock-based compensation		(32.2	)		1.4			66.5
Payments of contingent consideration		(17.3	)		–			–

Net cash used in financing activities		(208.1	)		(83.9	)		(106.2	)

Effect of foreign currency translation on cash balances		(9.7	)		10.8			(7.4	)

Increase in cash and cash equivalents		7.6			29.3			36.3
Cash and cash equivalents, beginning of year		224.4			195.1			158.8

Cash and cash equivalents, end of year	$	232.0		$	224.4		$	195.1

Our businesses include the production of pressure-sensitive materials and a variety of tickets, tags, labels and other converted products. We sell most of our pressure-sensitive materials to label printers and converters that convert the materials into labels and other products through embossing, printing, stamping and die-cutting. We sell other pressure-sensitive materials in converted form as tapes and reflective sheeting. We also manufacture and sell a variety of other converted products and items not involving pressure-sensitive components, such as fasteners, tickets, tags, radio-frequency identification ("RFID") inlays and tags, and imprinting equipment and related solutions, which serve the apparel and other end markets.

The consolidated financial statements include the accounts of majority-owned and controlled subsidiaries. Intercompany accounts, transactions, and profits are eliminated in consolidation. We apply the equity method of accounting for investments in which we have significant influence but not a controlling interest.

Certain amounts in the prior year's Consolidated Financial Statements have been reclassified to conform to the current year presentation.

In the first quarter of 2018, we adopted an accounting guidance update that provides a single comprehensive model on accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. We adopted this guidance using the modified retrospective method, which means that reporting periods beginning in 2018 are presented in accordance with this guidance, while prior period amounts continue to be reported in accordance with the previous guidance. As allowed by this guidance, we began to apply it to contracts with customers that were not completed as of the beginning of 2018. As a result of the adoption of this guidance, our allowance for customer returns, presented as a reduction of trade accounts receivable in prior years, is now presented as a returns liability in "Other accrued liabilities." As of December 29, 2018, the returns liability was $11.7 million. Our adoption of this guidance did not have a material impact on our financial position, results of operations, or cash flows. The disclosures required by this guidance are included in Note 15, "Segment and Disaggregated Revenue Information," and Note 16, "Supplemental Financial Information."

In the first quarter of 2018, we adopted an accounting guidance update that requires employers with defined benefit plans to present the service cost component of net periodic benefit cost in the same income statement line item(s) as other employee compensation costs arising from services rendered during the period. Employers are required to present the other components of net periodic benefit cost, including gains or losses from settlements or terminations, separately from the line item(s) that includes the service cost and outside of any subtotal of operating income. Components other than the service cost component are no longer eligible for capitalization in assets. Employers are required to apply the portion of this guidance on the presentation of the components of net periodic benefit cost in the income statement retrospectively, while the portion of this guidance that limits the capitalization of net periodic benefit cost in assets to the service cost component must be applied prospectively.

Prior year results have been reclassified as required by this guidance. The effects of our adoption of this guidance on our Consolidated Statements of Income for the prior years were as follows:

In the first quarter of 2018, we adopted an accounting guidance update that reduces the diversity in the presentation and classification of certain cash receipts and cash payments in statements of cash flows.

Prior year results have been reclassified as required by this guidance. The effects of our adoption of this guidance, which primarily relate to the classification of corporate-owned life insurance cash flows, on our Consolidated Statements of Cash Flows for the prior years were as follows:

In the first quarter of 2018, we adopted an accounting guidance update that requires recognition of the income tax effects of intra-entity sales and transfers of assets other than inventory in the period in which they occur. Upon adoption, we derecognized tax-related deferred charges and recognized deferred tax assets related to certain intra-entity asset transfers as a $13.8 million net reduction to retained earnings.

In the third quarter of 2018, we adopted an accounting guidance update that requires companies to capitalize implementation costs incurred in a hosting arrangement that is a service contract. We adopted this guidance early and on a prospective basis. Our adoption of this guidance did not have a material impact on our financial position, results of operations, or cash flows.

In the fourth quarter of 2018, we adopted an accounting update to improve the effectiveness of disclosures by removing and adding certain disclosures related to defined benefit plans. Refer to Note 6, "Pension and Other Postretirement Benefits," for more information.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or GAAP, requires management to make estimates and assumptions for the reporting period and as of the date of the financial statements. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenue and expense. Actual results could differ from these estimates.

Cash and cash equivalents generally consist of cash on hand, deposits in banks, cash-in-transit, and bank drafts and short-term investments with maturities of three months or less when purchased or received. The carrying value of these assets approximates fair value due to the short maturity of the instruments.

We record trade accounts receivable at the invoiced amount. The allowance for doubtful accounts reserve represents allowances for customer trade accounts receivable that are estimated to be partially or entirely uncollectible. These allowances are used to reduce gross trade receivables to their net realizable values. We record these allowances based on estimates related to the following:

No single customer represented 10% or more of our net sales in, or trade accounts receivable at, year-end 2018 or 2017. However, during 2018, 2017, and 2016, our ten largest customers by net sales in the aggregate represented approximately 15%, 15%, and 14% of our net sales, respectively. As of December 29, 2018 and December 30, 2017, our ten largest customers by trade accounts receivable in the aggregate represented approximately 14% of our trade accounts receivable. These customers were concentrated primarily in our Label and Graphic Materials reportable segment. We generally do not require our customers to provide collateral.

Inventories are stated at the lower of cost or net realizable value and categorized as raw materials, work-in-progress, or finished goods. Cost is determined using the first-in, first-out method. Inventory reserves are recorded to cost of products sold for damaged, obsolete, excess and slow-moving inventory and we establish a lower cost basis for the inventory. We use estimates to record these reserves. Slow-moving inventory is reviewed by category and may be partially or fully reserved for depending on the type of product, level of usage, and the length of time the product has been included in inventory.

Depreciation is generally computed using the straight-line method over the estimated useful lives of the assets, ranging from ten to forty-five years for buildings and improvements and three to fifteen years for machinery and equipment. Leasehold improvements are depreciated over the shorter of the useful life of the asset or the term of the associated leases. Maintenance and repair costs are expensed as incurred; renewals and betterments are capitalized. Upon the sale or retirement of assets, the accounts are relieved of the cost and the related accumulated depreciation, with any resulting gain or loss included in net income.

We capitalize internal and external software costs incurred during the application development stage of software development, including costs incurred for design, coding, installation to hardware, testing, and upgrades and enhancements that provide the software or hardware with additional functionalities and capabilities. Internal and external software costs during the preliminary project stage are expensed, as are those costs during the post-implementation and/or operation stage, including internal and external training costs and maintenance costs. In addition, we capitalize implementation costs incurred under a hosting arrangement that is a service contract. Capitalized software, which is included in "Other assets" in the Consolidated Balance Sheets, is amortized on a straight-line basis over the estimated useful life of the software, which is generally between five and ten years.

Impairment charges are recorded when the carrying amounts of long-lived assets are determined not to be recoverable. Recoverability is measured by comparing the undiscounted cash flows expected from their use and eventual disposition to the carrying value of the related asset or asset group. The amount of impairment loss is calculated as the excess of the carrying value over the fair value. Historically, changes in market conditions and management strategy have caused us to reassess the carrying amount of our long-lived assets.

Business combinations are accounted for using the acquisition method, with the excess of the acquisition cost over the fair value of net tangible assets and identified intangible assets acquired considered goodwill. As a result, we disclose goodwill separately from other intangible assets. Other identifiable intangibles include customer relationships, patents and other acquired technology, and trade names and trademarks.

In performing the required impairment tests, we have the option to first assess qualitative factors to determine whether it is necessary to perform a quantitative assessment for goodwill impairment. If the qualitative assessment indicates that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value, a quantitative assessment is performed. A quantitative assessment primarily consists of a present value (discounted cash flow) method to determine the fair value of the reporting units with goodwill. We perform our annual impairment test of goodwill during the fourth quarter.

In consultation with outside specialists, we estimate the fair value of our reporting units using various valuation techniques, with the primary technique being a discounted cash flow analysis. A discounted cash flow analysis requires us to make various assumptions about the reporting units, including forecasted sales, operating margins and growth rates, and discount rates. Assumptions about discount rates are based on a weighted-average cost of capital for comparable companies. Assumptions about sales, operating margins, and growth rates are based on our forecasts, business plans, economic projections, anticipated future cash flows, and marketplace data. Assumptions are also made for varying perpetual growth rates for periods beyond the long-term business plan period. We base our fair value estimates on projected financial information and assumptions that we believe are reasonable. However, actual future results may materially differ from these estimates and projections. The valuation methodology used to estimate the fair value of reporting units requires inputs and assumptions that reflect current market conditions, as well as the impact of planned business and operational strategies that require management judgment. The estimated fair value could increase or decrease depending on changes in the inputs and assumptions.

We test indefinite-lived intangible assets, consisting of trade names and trademarks, for impairment in the fourth quarter or whenever events or circumstances indicate that it is more likely than not that their carrying amounts exceed their fair values. Fair value is estimated as the discounted value of future revenues using a royalty rate that a third party would pay for use of the asset. Variation in the royalty rates could impact the estimate of fair value. If the carrying amount of an asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.

We amortize finite-lived intangible assets, consisting of customer relationships, patents and other acquired technology, trade names and trademarks, and other intangibles, on a straight-line basis over the estimated useful life of the assets.

See Note 3, "Goodwill and Other Intangibles Resulting from Business Acquisitions," for more information.

Asset and liability accounts of international operations are translated into U.S. dollars at current rates. Revenues and expenses are translated at the weighted-average currency rate for the fiscal year. Gains and losses resulting from hedging the value of investments in certain international operations and from the translation of balance sheet accounts are recorded directly as a component of other comprehensive income.

We enter into foreign exchange derivative contracts to reduce our risk from exchange rate fluctuations associated with receivables, payables, loans and firm commitments denominated in certain foreign currencies that arise primarily as a result of our operations outside the U.S. From time to time, we enter into interest rate contracts to help manage our exposure to certain interest rate fluctuations. We also enter into futures contracts to hedge certain price fluctuations for a portion of our anticipated domestic purchases of natural gas. The maximum length of time for which we hedge our exposure to the variability in future cash flows for forecasted transactions is 36 months.

On the date we enter into a derivative contract, we determine whether the derivative will be designated as a hedge. Derivatives designated as hedges are classified as either (1) hedges of the fair value of a recognized asset or liability or an unrecognized firm commitment ("fair value" hedges) or (2) hedges of a forecasted transaction or the variability of cash flows that are to be received or paid in connection with a recognized asset or liability ("cash flow" hedges). Other derivatives not designated as hedges are recorded on the balance sheets at fair value, with changes in fair value recognized in earnings. Our policy is not to purchase or hold any foreign currency, interest rate or commodity contracts for trading purposes.

We assess, both at the inception of the hedge and on an ongoing basis, whether our hedges are highly effective. If it is determined that a hedge is not highly effective, we prospectively discontinue hedge accounting. For cash flow hedges, the effective portion of the related gains and losses is recorded as a component of other comprehensive income, and the ineffective portion is reported in earnings. Amounts in accumulated other comprehensive income (loss) are reclassified into earnings in the same period during which the hedged transaction

affects earnings. In the event that the anticipated transaction is no longer likely to occur, we recognize the change in fair value of the instrument in current period earnings. Changes in fair value hedges are recognized in current period earnings. Changes in the fair value of underlying hedged items (such as recognized assets or liabilities) are also recognized in current period earnings and offset the changes in the fair value of the derivative.

In the Consolidated Statements of Cash Flows, hedges are classified in the same category as the item hedged, primarily in operating activities.

We also utilize certain foreign-currency-denominated debt to mitigate our foreign currency translation exposure from our net investment in foreign operations.

We define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability.

We determine fair value based on a three-tier fair value hierarchy, which we use to prioritize the inputs used in measuring fair value. These tiers consist of Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring us to develop our own assumptions to determine the best estimate of fair value.

Sales are recognized when or as we satisfy a performance obligation by transferring control of a product or service to a customer, in an amount that reflects the consideration to which we expect to be entitled in exchange for the product or service. We consider a number of factors in determining when we have transferred control to a customer, including the following: (i) our present right to payment; (ii) the customer's legal title to the asset; (iii) physical possession of the asset; (iv) the customer's significant risks and rewards of ownership of the asset; and (v) the customer's acceptance of the asset.

Generally, payment terms with our customers are consistent with those used in our industries and the regions in which we operate.

Sales returns are accepted in certain limited circumstances. We record an estimate for returns liabilities and a corresponding reduction to sales, in the amount we expect to repay or credit customers, which we base on historical returns and outstanding customer claims. Changes in estimates are updated each reporting period.

Sales rebates, discounts, and other customer concessions are common in the industries and regions in which we operate and are accounted for as a reduction to sales based on estimates at the time at which products are sold. These estimates are based on our historical experience, as well as current information such as sales forecasts. We review our estimates regularly and, as additional information becomes available, we adjust our sales and the respective accruals, if necessary.

Sales tax, value-added tax, and other taxes we collect from customers are excluded from sales. Shipping and handling activities after control of a product is transferred to a customer are accounted for as fulfillment costs and not as separate performance obligations. As a practical expedient, we have elected not to disclose the value of unsatisfied performance obligations for contracts with an original expected length of less than one year. We generally expense sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded in "Marketing, general and administrative expense" in the Consolidated Statements of Income.

Research and development costs are related to research, design, and testing of new products and applications and are expensed as incurred.

We estimate expected forfeitures in determining the compensation cost to be recognized each period, rather than accounting for forfeitures as they occur.

No long-term incentive compensation expense was capitalized in 2018, 2017, or 2016.

Changes in estimated forfeiture rates are recorded as cumulative adjustments in the period that the estimates are revised.

Our stock-based compensation expense is based on the fair value of awards, adjusted for estimated forfeitures, and amortized on a straight-line basis over the requisite service period for stock options and restricted stock units ("RSUs"). Compensation expense for performance units ("PUs") is based on the fair value of awards, adjusted for estimated forfeitures, and amortized on a straight-line basis as these awards cliff-vest at the end of the requisite service period. The compensation expense related to market-leveraged stock units ("MSUs") is based on the fair value of awards, adjusted for estimated forfeitures, and amortized on a graded-vesting basis over their respective performance periods.

The fair value of RSUs and the component of PUs that is subject to the achievement of a performance objective based on a financial performance condition is determined based on the fair market value of our common stock as of the date of grant, adjusted for foregone dividends.

Our provision for income taxes is determined using the asset and liability approach in accordance with GAAP. Under this approach, deferred income taxes represent the expected future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities. We record a valuation allowance to reduce our deferred tax assets when uncertainty regarding their realizability exists. We recognize and measure our uncertain tax positions following the more likely than not threshold for financial statement recognition and measurement for tax positions taken or expected to be taken in a tax return.

In November 2018, the Financial Accounting Standards Board ("FASB") issued guidance that clarifies the interaction between guidance regarding collaborative arrangements and revenue from contracts with customers. This guidance is effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted. We are currently assessing the impact of this guidance on our financial position, results of operations, cash flows, and disclosures.

In February 2018, the FASB issued guidance that provides entities with the option to reclassify certain tax effects of the TCJA in accumulated other comprehensive income to retained earnings. This guidance can be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal income tax rate pursuant to the TCJA is recognized. The guidance is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted for reporting periods for which financial statements have yet to be issued or made available for issuance. We do not expect to reclassify the tax benefits included in accumulated other comprehensive income to retained earnings upon adoption. We also do not anticipate that our adoption will have a significant impact on our financial position, results of operations, cash flows, or disclosures.

In August 2017, the FASB issued amended guidance to improve the financial reporting of hedging relationships to better reflect the economic results of an entity's risk management activities in its financial statements, as well as to simplify the application of hedge accounting. Adoption of this amended guidance is required prospectively. This guidance is effective for interim and annual periods beginning after December 15, 2018, and early adoption is permitted. We do not anticipate that our adoption will have a significant impact on our financial position, results of operations, cash flows, or disclosures.

In June 2016, the FASB issued revised guidance on the measurement of credit losses on financial instruments. Credit losses on loans, trade and other receivables, held-to-maturity debt securities, and other instruments will reflect the current estimate of the expected credit losses. This guidance is effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted. We do not anticipate that the adoption of this guidance will have a significant impact on our financial position, results of operations, cash flows, and disclosures.

In March 2016, and in subsequent updates, the FASB issued guidance on accounting for leases that requires lessees to recognize the rights and obligations created by leases on their balance sheets. This guidance also requires enhanced disclosures regarding the amount, timing, and uncertainty of cash flows arising from leases and is effective for interim and annual periods beginning after December 15, 2018. As allowed under this guidance, we have elected to apply the guidance under a modified retrospective approach, under which this guidance applies to all leases that exist at or commence after the date of initial application, with the option to use certain practical expedients. We plan to elect the transition practical expedients allowed under this guidance. As discussed in Note 7. "Commitments," we have operating leases with remaining minimum lease payments totaling approximately $185 million, and, upon transition, we will record right of use assets and lease liabilities related to these leases. We established a cross-functional team to manage the assessment, design, and implementation of this new guidance. We are continuing to implement processes and information technology tools and to evaluate our accounting policies and controls to address this guidance and are in the process of coordinating our transition to the revised guidance. We anticipate the adoption of this guidance will have a significant impact on our financial position and disclosures and are in the process of assessing its impact on our results of operations and cash flows.

On June 23, 2017, we completed the stock acquisition of Yongle Tape Ltd. ("Yongle Tape"), a China-based manufacturer of specialty tapes and related products used in a variety of industrial markets, from Yongle Tape's management and Shaw Kwei & Partners.

On May 19, 2017, we completed the stock acquisition of Finesse Medical Limited ("Finesse Medical"), an Ireland-based manufacturer of healthcare products used in the management of wound care and skin conditions, from Finesse Medical's management.

On March 1, 2017, we completed the net asset acquisition of Hanita Coatings Rural Cooperative Association Limited and stock acquisition of certain of its subsidiaries ("Hanita"), an Israel-based pressure-sensitive manufacturer of specialty films and laminates, from Kibbutz Hanita Coatings and Tene Investment Funds.

The aggregate purchase consideration for these acquisitions (the "2017 Acquisitions") was approximately $340 million. The 2017 Acquisitions were funded through cash and existing credit facilities.

The 2017 Acquisitions were not material, individually or in the aggregate, to our Consolidated Financial Statements.

On August 1, 2016, we completed the acquisition of the European business of Mactac ("Mactac") from Platinum Equity through the purchase of Evergreen Holdings V, LLC. The total consideration for this acquisition, net of cash received, was approximately $220 million, which we funded primarily through existing credit facilities. This acquisition was not material to our Consolidated Financial Statements.

Results from our annual goodwill impairment test in the fourth quarter of 2018 indicated that no impairment occurred during 2018. The assumptions used in the assessment of these assets were primarily based on Level 3 inputs.

Changes in the net carrying amount of goodwill for 2018 and 2017 by reportable segment were as follows:

(In millions)	Label and Graphic Materials			Retail Branding and Information Solutions			Industrial and Healthcare Materials			Total


Goodwill as of December 31, 2016	$	373.3		$	353.9		$	66.4		$	793.6
2017 Acquisitions(1)		17.5			–			125.5			143.0
Acquisition adjustments(2)		4.8			–			.7			5.5
Translation adjustments		33.9			1.5			7.6			43.0

Goodwill as of December 30, 2017		429.5			355.4			200.2			985.1
Acquisition adjustments(3)		–			–			(17.7	)		(17.7	)
Translation adjustments		(14.0	)		(5.7	)		(5.9	)		(25.6	)

Goodwill as of December 29, 2018	$	415.5		$	349.7		$	176.6		$	941.8

The carrying amounts of goodwill at December 29, 2018 and December 30, 2017 were net of accumulated impairment losses of $820 million recognized in fiscal year 2009 by our Retail Branding and Information Solutions ("RBIS") reportable segment.

Results from our annual indefinite-lived intangible assets impairment test in the fourth quarter indicated that no impairment occurred in 2018.

The carrying value of indefinite-lived intangible assets resulting from business acquisitions, consisting of trade names and trademarks, was $21.1 million and $21.2 million at December 29, 2018 and December 30, 2017, respectively. In connection with the Mactac acquisition, we acquired approximately $13 million of indefinite-lived intangible assets in 2016, which consist of trade names. These intangible assets were not subject to amortization as they were classified as indefinite-lived assets.

In connection with the 2017 Acquisitions, we acquired approximately $107 million of identifiable intangible assets, which consisted of customer relationships, trade names and trademarks, and patents and other acquired technology. We utilized the income approach to estimate the fair values of the identifiable intangibles associated with the 2017 Acquisitions, using primarily Level 3 inputs. The discount rates we used to value these assets were between 11% and 16.5%.

The table below summarizes the amounts and weighted useful lives of these intangible assets at acquisition.

In connection with the Mactac acquisition, we acquired approximately $29 million of identifiable intangible assets in 2016, which consisted of customer relationships and patents and other acquired technology. We utilized an income approach to estimate the fair values of the identifiable intangibles acquired from Mactac, using primarily Level 3 inputs. The discount rates we used to value these assets were between 10.5% and 12.5%.

The table below summarizes the amounts and weighted useful lives of these intangible assets at acquisition.

The following table sets forth our finite-lived intangible assets resulting from business acquisitions at December 29, 2018 and December 30, 2017, which continue to be amortized:

Amortization expense for finite-lived intangible assets resulting from business acquisitions was $15.2 million for 2018, $18.6 million for 2017, and $19.9 million for 2016.

The estimated amortization expense for finite-lived intangible assets resulting from business acquisitions for each of the next five fiscal years is expected to be as follows:

We had $131 million and $183.8 million of borrowings from U.S. commercial paper issuances outstanding at December 29, 2018 and December 30, 2017, respectively, with a weighted-average interest rate of 2.75% and 1.79%, respectively.

In March 2016, we entered into an agreement to establish a Euro-Commercial Paper Program pursuant to which we may issue unsecured commercial paper notes up to a maximum aggregate amount outstanding of $500 million. Proceeds from issuances under this program may be used for general corporate purposes. The maturities of the notes may vary, but may not exceed 364 days from the date of issuance. Our payment obligations with respect to any notes issued under this program are backed by our revolving credit facility (the "Revolver"). There are no financial covenants under this program. As of December 29, 2018, there was no balance outstanding under this program.

No balance was outstanding under the Revolver as of December 29, 2018 or December 30, 2017. Commitment fees associated with the Revolver in 2018, 2017, and 2016 were $1.2 million, $1.1 million, and $1.1 million, respectively.

From time to time, certain of our subsidiaries provide guarantees on certain arrangements with banks. Our exposure to these guarantees is not material.

In December 2018, we issued $500 million of senior notes, due December 2028. The senior notes bear an interest rate of 4.875% per year, payable semiannually in arrears. The net proceeds from the offering, after deducting underwriting discounts and offering expenses, were $493.3 million, which we used to repay commercial paper borrowings. Prior to the issuance of these senior notes, we used commercial paper borrowings in the third quarter to fund our $200 million contribution to the Avery Dennison Pension Plan ("ADPP") in connection with its termination. Refer to Note 6, "Pension and Other Postretirement Benefits."

In March 2017, we issued €500 million of senior notes, due March 2025. The senior notes bear an interest rate of 1.25% per year, payable annually in arrears. The net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses, were $526.6 million (€495.5 million), a portion of which we used to repay commercial paper borrowings used to finance a portion of our purchase price for the acquisition of Mactac, and the remainder of which we used for general corporate purposes and the 2017 Acquisitions. We designated a portion of these senior notes as a net investment hedge of our investment in foreign operations. Refer to Note 5, "Financial Instruments," for more information.

Long-term debt, including its respective interest rates, and capital lease obligations at year-end consisted of the following:

(In millions)	2018			2017


Long-term debt and capital leases
Medium-term notes:
Series 1995 due 2020 through 2025	$	45.0		$	44.9
Long-term notes:
Senior notes due 2020 at 5.4%		249.7			249.5
Senior notes due 2023 at 3.4%		248.9			248.7
Senior notes due 2025 at 1.25%(1)		569.0			588.4
Senior notes due 2028 at 4.875%		493.3			–
Senior notes due 2033 at 6.0%		148.8			148.7
Capital leases		20.7			25.0
Other borrowings(2)		14.4			16.6
Less amount classified as current		(18.2	)		(5.5	)

Total long-term debt and capital leases(3)	$	1,771.6		$	1,316.3

At year-end 2018 and 2017, our medium-term notes had maturities from 2020 through 2025 and accrued interest at a weighted-average fixed rate of 7.5%.

We expect maturities of long-term debt and capital lease payments for each of the next five fiscal years and thereafter to be as follows:

The maturities of capital lease payments in the table above include $3 million of imputed interest, $1 million of which is expected to be paid in 2019.

The Revolver contains financial covenants requiring that we maintain specified ratios of total debt and interest expense in relation to certain measures of income. As of December 29, 2018 and December 30, 2017, we were in compliance with our financial covenants.

Our total interest costs in 2018, 2017, and 2016 were $63.8 million, $67.9 million, and $63.5 million, respectively, of which $5.3 million, $4.9 million, and $3.6 million, respectively, was capitalized as part of the cost of assets.

The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities or euro government bond securities, as applicable, on notes with similar rates, credit ratings, and remaining maturities. The fair value of short-term borrowings, which includes commercial paper issuances and short-term lines of credit, approximates carrying value given the short duration of these obligations. The fair value of our total debt was $2 billion at December 29, 2018 and $1.6 billion at December 30, 2017. Fair value amounts were determined based primarily on Level 2 inputs, which are inputs other than quoted prices in active markets that are either directly or indirectly observable. Refer to Note 1, "Summary of Significant Accounting Policies," for more information.

As of December 29, 2018, the aggregate U.S. dollar equivalent notional value of our outstanding commodity contracts and foreign exchange contracts was $3.2 million and $1.33 billion, respectively.

We recognize derivative instruments as either assets or liabilities at fair value in the Consolidated Balance Sheets. We designate commodity forward contracts on forecasted purchases of commodities and foreign exchange contracts on forecasted transactions as cash flow hedges. We also enter into foreign exchange contracts to offset risks arising from foreign exchange rate fluctuations.

The following table shows the fair value and balance sheet locations of cash flow hedges as of December 29, 2018 and December 30, 2017:

The following table shows the fair value and balance sheet locations of other derivatives as of December 29, 2018 and December 30, 2017:

For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of "Accumulated other comprehensive loss" and reclassified into earnings in the same period(s) during which the hedged transaction impacts earnings. Gains and losses on the derivatives, representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness, are recognized in current earnings.

Gains (losses), before taxes, recognized in "Accumulated other comprehensive loss" (effective portion) on derivatives related to cash flow hedge contracts were as follows:

The amounts recognized in income related to the ineffective portion of, and the amount excluded from, effectiveness testing for cash flow hedges and derivatives not designated as hedging instruments were immaterial in 2018, 2017, and 2016.

As of December 29, 2018, we expected a net loss of approximately $.4 million to be reclassified from "Accumulated other comprehensive loss" to earnings within the next 12 months.

For other derivative instruments, which are not designated as hedging instruments, the gain or loss is recognized in current earnings. These derivatives are intended to offset certain of our economic exposures. The following table shows the components of the net gains (losses) recognized in income related to these derivative instruments.

In March 2017, we designated €500 million of our 1.25% senior notes due 2025 as a net investment hedge of our investment in foreign operations. In January 2018, we reduced the amount we designate as a net investment hedge to €255 million. The net assets from the investment in foreign operations were greater than the senior notes, and as such, the net investment hedge was effective.

Gains (losses), before tax, recognized in "Accumulated other comprehensive loss" (effective portion) related to the net investment hedge were as follows:

We recorded no ineffectiveness from our net investment hedge in earnings during 2018 or 2017.

We sponsor a number of defined benefit plans, the accrual of benefits under some of which has been frozen, covering eligible employees in the U.S. and certain other countries. Benefits payable to an employee are based primarily on years of service and the employee's compensation during the course of his or her employment with us.

We are also obligated to pay unfunded termination indemnity benefits to certain employees outside of the U.S., which are subject to applicable agreements, laws and regulations. We have not incurred significant costs related to these benefits, and, therefore, no related costs are included in the disclosures below.

In July 2018, our Board of Directors ("Board") approved the termination of the ADPP, a U.S. defined benefit plan, effective as of September 28, 2018. In connection with the termination, we contributed $200 million to the ADPP in August 2018 using U.S. commercial paper borrowings. During the fourth quarter of 2018, we settled approximately $152 million of the ADPP liability through lump-sum payments from existing plan assets to eligible participants who elected to receive them and recorded approximately $85 million of non-cash charges associated with these settlements. We expect to settle the remaining liability of approximately $792 million through the purchase of a group annuity contract(s) from one or more yet-to-be-identified highly rated insurance companies in the first half of 2019. Upon transfer of this remaining liability, we expect to recognize an additional $490 million of non-cash pretax charges and related tax benefits of $190 million. As of December 29, 2018, the ADPP was underfunded by approximately $57 million.

In December 2015, we offered eligible former employees who were vested participants in the ADPP the opportunity to receive their benefits immediately as either a lump-sum payment or an annuity, rather than waiting until they are retirement eligible under the terms of the plan. In the second quarter of 2016, approximately $70 million of pension obligations related to the ADPP were settled from existing plan assets and a non-cash pre-tax settlement charge of $41.4 million was recorded in "Other expense, net" in the Consolidated Statements of Income. This settlement required us to remeasure the remaining net pension obligations of the ADPP. As a result, in 2016, we recognized approximately $72 million of additional net pension obligations with a corresponding increase in actuarial losses recorded in "Accumulated other comprehensive loss," primarily due to lower discount rates in effect when the plan was remeasured.

Our investment management of our ADPP assets utilizes a liability driven investment (LDI) strategy. Under an LDI strategy, the assets are invested in a diversified portfolio that consists primarily of investment grade fixed income securities and cash. This strategy is intended to more closely match the short-term liabilities of the plan. The investment objective of the portfolio is to improve the funded status of the plan; as funded status reaches certain trigger points, the portfolio moves to a more conservative asset allocation, hedging more of the interest rate risk of the plan's liabilities. The investment portfolio is designed to hedge the plan's liabilities and balance risk and return within the limits of

prudent risk-taking and Section 404 of the Employee Retirement Income Security Act of 1974, as amended.

Assets in our international plans are invested in accordance with locally accepted practices and primarily include equity securities, fixed income securities, insurance contracts and cash. Asset allocations and investments vary by country and plan. Our target plan asset investment allocation for our international plans combined is 32% in equity securities, 44% in fixed income securities and cash, and 24% in insurance contracts and other investments, subject to periodic fluctuations in these respective asset classes.

The valuation methodologies we use for assets measured at fair value are described below.

Cash is valued at nominal value. Cash equivalents and mutual funds are valued at fair value as determined by quoted market prices, based upon the net asset value ("NAV") of shares held at year-end. Fixed income treasury securities are valued at fair value as determined by quoted prices in active markets. The fixed income municipal and corporate bonds are valued at fair value based on quoted prices for similar instruments in active markets or other inputs that are observable or can be corroborated by observable market data. Pooled funds are structured as collective trusts, not publicly traded, and valued by calculating NAV per unit based on the NAV of the underlying funds/trusts as a practical expedient for the fair value of the pooled funds. Insurance contracts are valued at book value, which approximates fair value and is calculated using the prior year balance plus (minus) investment returns and changes in cash flows.

These methods may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while we believe the valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

The following table sets forth, by level within the fair value hierarchy (as applicable), U.S. plan assets (all in the ADPP) at fair value:

			Fair Value Measurements Using

(In millions)	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)

2018
Cash and cash equivalents	$	27.1	$	27.1	$	–	$	–
Equity securities		.3		–		.3		–
Fixed income securities – government and municipal bonds		113.0		66.3		46.7		–
Fixed income securities – corporate bonds		592.8		–		592.8		–
Other		2.4		–		2.4		–

Total U.S. plan assets	$	735.6

2017
Cash	$	–	$	–	$	–	$	–
Pooled funds – liability-hedging portfolio(1)		275.6
Pooled funds – growth portfolio(1)		464.6

Total U.S. plan assets	$	740.2

The following table sets forth, by level within the fair value hierarchy (as applicable), international plan assets at fair value:

			Fair Value Measurements Using

(In millions)	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)

2018
Cash	$	4.1	$	4.1	$	–	$	–
Insurance contracts		36.9		–		–		36.9
Pooled funds – fixed income securities(1)		300.4
Pooled funds – equity securities(1)		185.0
Pooled funds – other investments(1)		105.4

Total international plan assets at fair value	$	631.8

2017
Cash	$	1.7	$	1.7	$	–	$	–
Insurance contracts		35.7		–		–		35.7
Pooled funds – fixed income securities(1)		278.5
Pooled funds – equity securities(1)		277.3
Pooled funds – other investments(1)		90.5

Total international plan assets at fair value	$	683.7

The following table presents a reconciliation of Level 3 international plan asset activity during the year ended December 29, 2018:

We provide postretirement health benefits to certain retired U.S. employees up to the age of 65 under a cost-sharing arrangement and provide supplemental Medicare benefits to certain U.S. retirees over the age of 65. Our policy is to fund the cost of the postretirement benefits from operating cash flows. While we have not expressed any intent to terminate postretirement health benefits, we may do so at any time, subject to applicable laws and regulations.

In consultation with our actuaries, we annually review and determine the discount rates used to value our postretirement obligations. With the exception of the ADPP, the assumed discount rate for each pension plan reflects market rates for high quality corporate bonds currently available. Our discount rate is determined by evaluating yield curves consisting of large populations of high quality corporate bonds. The projected pension benefit payment streams are then matched with bond portfolios to determine a rate that reflects the liability duration unique to our plans. As of December 29, 2018, the discount rate for the ADPP, after reflecting the plan's termination, was based on estimated insurer pricing.

We measure the actuarial value of our benefit obligations and plan assets using the calendar month-end closest to our fiscal year-end and adjust for any contributions or other significant events between the measurement date and our fiscal year-end.

The following table provides a reconciliation of benefit obligations, plan assets, funded status of the plans and accumulated other comprehensive loss for our defined benefit plans:

	Pension Benefits												U.S. Postretirement Health Benefits

	2018						2017						2018			2017
(In millions)	U.S.			Int'l			U.S.			Int'l

Change in projected benefit obligations
Projected benefit obligations at beginning of year	$	1,082.1		$	836.7		$	1,033.7		$	762.9		$	4.1		$	5.0
Service cost		–			19.2			.5			18.2			–			–
Interest cost		34.5			15.7			35.3			14.3			.1			.1
Participant contribution		–			3.8			–			3.4			.5			.5
Amendments		–			–			–			(2.1	)		–			–
Actuarial (gain) loss		(13.2	)		(58.8	)		73.1			(26.4	)		.2			(.1	)
Plan transfers		–			–			–			(1.3	)		–			–
Benefits paid		(61.8	)		(22.3	)		(60.5	)		(22.5	)		(1.1	)		(1.4	)
Settlements(1)		(173.1	)		(9.5	)		–			–			–			–
Foreign currency translation		–			(29.0	)		–			90.2			–			–

Projected benefit obligations at end of year	$	868.5		$	755.8		$	1,082.1		$	836.7		$	3.8		$	4.1

Accumulated benefit obligations at end of year	$	868.5		$	696.7		$	1,082.1		$	775.6

	Pension Benefits												U.S. Postretirement Health Benefits

	2018						2017						2018			2017
(In millions)	U.S.			Int'l			U.S.			Int'l

Change in plan assets
Plan assets at beginning of year	$	740.2		$	683.7		$	672.1		$	584.2		$	–		$	–
Actual return on plan assets		(3.6	)		(13.3	)		90.1			34.2			–			–
Plan transfers		–			–			–			(.7	)		–			–
Employer contributions(1)		233.9			14.7			38.5			14.0			.6			.9
Participant contributions		–			3.8			–			3.4			.5			.5
Benefits paid		(61.8	)		(22.3	)		(60.5	)		(22.5	)		(1.1	)		(1.4	)
Settlements(2)		(173.1	)		(9.5	)		–			–			–			–
Foreign currency translation		–			(25.3	)		–			71.1			–			–

Plan assets at end of year	$	735.6		$	631.8		$	740.2		$	683.7		$	–		$	–

For U.S. and international plans combined, the projected benefit obligations and fair value of plan assets for pension plans with projected benefit obligations in excess of plan assets were $1.47 billion and $1.20 billion, respectively, at year-end 2018 and $1.92 billion and $1.42 billion, respectively, at year-end 2017.

For U.S. and international plans combined, the accumulated benefit obligations and fair value of plan assets for pension plans with accumulated benefit obligations in excess of plan assets were $1.02 billion and $792 million, respectively, at year-end 2018 and $1.44 billion and $994 million, respectively, at year-end 2017.

The following table sets forth the pre-tax amounts recognized in "Accumulated other comprehensive loss" in the Consolidated Balance Sheets:

The following table sets forth the pre-tax amounts recognized in "Other comprehensive loss (income)":

	Pension Benefits																		U.S. Postretirement Health Benefits

	2018						2017						2016						2018			2017			2016
(In millions)	U.S.			Int'l			U.S.			Int'l			U.S.			Int'l

Net actuarial loss (gain)	$	33.5		$	(27.2	)	$	21.8		$	(17.2	)	$	39.1		$	48.9		$	.2		$	–		$	(.2	)
Prior service credit		–			–			–			(2.1	)		–			(.6	)		–			–			–
Amortization of unrecognized:
Net actuarial loss		(21.2	)		(8.1	)		(18.7	)		(10.8	)		(19.0	)		(7.0	)		(1.4	)		(1.5	)		(1.7	)
Prior service (cost) credit		(.8	)		.5			(.9	)		.4			(1.2	)		.4			3.3			3.3			3.2
Net transition obligation		–			–			–			–			–			(.1	)		–			–			–
Settlements		(92.0	)		(1.7	)		–			–			(41.4	)		–			–			–			–

Net amount recognized in other comprehensive (income) loss	$	(80.5	)	$	(36.5	)	$	2.2		$	(29.7	)	$	(22.5	)	$	41.6		$	2.1		$	1.8		$	1.3

The following table sets forth the components of net periodic benefit cost, which are recorded in net income for our defined benefit plans:

	Pension Benefits																		U.S. Postretirement Health Benefits

	2018						2017						2016						2018			2017			2016
(In millions)	U.S.			Int'l			U.S.			Int'l			U.S.			Int'l

Service cost	$	–		$	19.2		$	.5		$	18.2		$	.4		$	13.9		$	–		$	–		$	–
Interest cost		34.5			15.7			35.3			14.3			34.4			16.4			.1			.1			.1
Actuarial (gain) loss		(.6	)		–			1.7			–			(.2	)		–			–			–			–
Expected return on plan assets		(42.5	)		(23.8	)		(40.5	)		(21.1	)		(42.7	)		(21.4	)		–			–			–
Amortization of actuarial loss		21.2			8.1			18.7			10.8			19.0			7.0			1.4			1.5			1.7
Amortization of prior service cost (credit)		.8			(.5	)		.9			(.4	)		1.2			(.4	)		(3.3	)		(3.3	)		(3.2	)
Amortization of transition obligation		–			–			–			–			–			.1			–			–			–
Recognized net gain on curtailments		–			–			–			–			–			(.2	)		–			–			–
Recognized loss on settlements(1)		92.0			1.7			–			–			41.4			–			–			–			–

Net periodic benefit cost (credit)	$	105.4		$	20.4		$	16.6		$	21.8		$	53.5		$	15.4		$	(1.8	)	$	(1.7	)	$	(1.4	)

The following table sets forth the weighted-average assumptions used to determine net periodic cost:

We make contributions to our defined benefit plans sufficient to meet the minimum funding requirements of applicable laws and regulations, plus additional amounts, if any, we determine to be appropriate. The following table sets forth our expected contributions in 2019:

The future benefit payments shown below, which reflect expected service periods for eligible participants, exclude estimates for the ADPP. We expect to settle the future benefit payments for the ADPP in the first half of 2019. These payments are estimated to be $792 million and have been included in the projected benefit obligation table above.

We sponsor various defined contribution plans worldwide, the largest of which is the Avery Dennison Corporation Employee Savings Plan ("Savings Plan"), a 401(k) plan for our U.S. employees.

We recognized expense of $21.8 million, $20.2 million, and $20 million in 2018, 2017, and 2016, respectively, related to our employer contributions and employer match of participant contributions to the Savings Plan.

We have deferred compensation plans that permit eligible employees and directors to defer a portion of their compensation. The compensation voluntarily deferred by the participant, together with certain employer contributions, earns specified and variable rates of return. As of year-end 2018 and 2017, we had accrued $84.3 million and $86.9 million, respectively, for our obligations under these plans. A portion of the interest on certain of our contributions may be forfeited by participants if their employment terminates before age 55 other than by reason of death or disability.

Our Directors Deferred Equity Compensation Program allows our non-employee directors to elect to receive their cash compensation in deferred stock units ("DSUs") issued under our equity plans. Additionally, two legacy deferred compensation plans had DSUs that were issued under our equity plans. Dividend equivalents, representing the value of dividends per share paid on shares of our common stock and calculated with reference to the number of DSUs held as of a quarterly dividend record date, are credited in the form of additional DSUs on the applicable payable date. DSUs are converted into shares of our common stock upon his or her resignation or retirement. Approximately .2 million and .2 million DSUs were outstanding as of year-end 2018 and 2017, respectively, with an aggregate value of $17 million and $20.9 million, respectively.

We hold corporate-owned life insurance policies, the proceeds from which are payable to us upon the death of covered participants. The cash surrender values of these policies, net of outstanding loans, which are included in "Other assets" in the Consolidated Balance Sheets, were $227.4 million and $243.5 million at year-end 2018 and 2017, respectively.

Minimum annual rental commitments on operating leases having initial or remaining non-cancelable lease terms of one year or more are as follows:

Rent expense for operating leases was approximately $66 million in 2018, $64 million in 2017, and $58 million in 2016. Operating leases primarily relate to office and warehouse space and equipment for information technology, machinery, and transportation. These leases do not impose significant restrictions or unusual obligations.

We are involved in various lawsuits, claims, inquiries, and other regulatory and compliance matters, most of which are routine to the nature of our business. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these claims could affect future results of operations should our exposure be materially different from our estimates or should liabilities be incurred that were not previously accrued. Potential insurance reimbursements are not offset against potential liabilities.

Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve these matters could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our accrued liabilities accordingly. Additional lawsuits, claims, inquiries, and other regulatory and compliance matters could arise in the future. The range of expenses for resolving any future matters would be assessed as they arise; until then, a range of potential expenses for such resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of these matters would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows.

Environmental expenditures are generally expensed. However, environmental expenditures for newly acquired assets and those which extend or improve the economic useful life of existing assets are capitalized and amortized over the shorter of the estimated useful life of the acquired asset or the remaining life of the existing asset. We review our estimates of costs of compliance with environmental laws related to remediation and cleanup of various sites, including sites in which governmental agencies have designated us as a potentially responsible party ("PRP"). When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. Potential insurance reimbursements are not offset against potential liabilities.

As of December 29, 2018, we have been designated by the U.S. Environmental Protection Agency ("EPA") and/or other responsible state agencies as a PRP at thirteen waste disposal or waste recycling sites that are the subject of separate investigations or proceedings concerning alleged soil and/or groundwater contamination. No settlement of our liability related to any of the sites has been agreed upon. We are participating with other PRPs at these sites and anticipate that our share of remediation costs will be determined pursuant to agreements that we negotiate with the EPA or other governmental authorities.

These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, the estimated time to complete remediation, environmental laws and regulations, and other factors. Because of the uncertainties associated with environmental assessment and remediation activities, future expenses to remediate these sites could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our environmental liabilities accordingly. In addition, we may be identified as a PRP at additional sites in the future. The range of expenses for remediation of any future-identified sites would be addressed as they arise; until then, a range of expenses for such remediation cannot be determined.

The activity in 2018 and 2017 related to our environmental liabilities was as follows:

As of December 29, 2018 and December 30, 2017, approximately $5 million and $5 million, respectively, of the balance was classified as short-term and included in "Other accrued liabilities" in the Consolidated Balance Sheets.

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of December 29, 2018:

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of December 30, 2017:

Trading securities include fixed income securities (primarily U.S. government and corporate debt securities) measured at fair value using quoted prices/bids and a money market fund measured at fair value using NAV. As of December 29, 2018, trading securities of $.2 million and $26.1 million were included in "Cash and cash equivalents" and "Other current assets," respectively, in the Consolidated Balance Sheets. As of December 31, 2017, trading securities of $.4 million and $22.3 million were included in "Cash and cash equivalents" and "Other current assets," respectively, in the Consolidated Balance Sheets. Derivatives that are exchange-traded are measured at fair value using quoted market prices and classified within Level 1 of the valuation hierarchy. Derivatives measured based on foreign exchange rate inputs that are readily available in public markets are classified within Level 2 of the valuation hierarchy. Bank drafts (maturities greater than three months) are valued at face value due to their short-term nature and were included in "Other current assets" in the Consolidated Balance Sheets. Contingent consideration liabilities relate to estimated earn-out payments associated with certain of the 2017 Acquisitions. These payments are based on the achievement of certain performance targets in 2017 and 2018 based on the applicable terms of the purchase agreements, and our estimates are based on the expected payments related to these targets under the terms of their respective agreements. We have classified these liabilities as Level 3. As of December 29, 2018, contingent consideration liabilities were included in "Other accrued liabilities" in the Consolidated Balance Sheets. As of December 30, 2017, contingent consideration liabilities of approximately $18 million and $27 million were included in "Other accrued liabilities" and "Long-term retirement benefits and other liabilities," respectively, in the Consolidated Balance Sheets.

The following table presents a reconciliation of Level 3 contingent consideration liabilities for the year ended December 29, 2018:

During the year ended December 29, 2018, long-lived assets with carrying amounts totaling $18.1 million were written down to their fair value of $10.6 million, resulting in an impairment charge of $7.5 million,

which was included in "Other expense, net" in the Consolidated Statements of Income. The fair value was based on the estimated sale price of the assets, less estimated broker fees, which is primarily a Level 3 input.

(In millions, except per share amounts)		2018		2017		2016


(A)	Net income available to common shareholders	$	467.4	$	281.8	$	320.7

(B)	Weighted average number of common shares outstanding		87.3		88.3		89.1
	Dilutive shares (additional common shares issuable under stock-based awards)		1.3		1.8		1.6

(C)	Weighted average number of common shares outstanding, assuming dilution		88.6		90.1		90.7

Net income per common share: (A) ÷ (B)		$	5.35	$	3.19	$	3.60

Net income per common share, assuming dilution (A) ÷ (C)		$	5.28	$	3.13	$	3.54

Stock-based compensation awards excluded from the computation of net income per common share, assuming dilution, because they would not have had a dilutive effect were as follows:

Our Certificate of Incorporation authorizes five million shares of $1 par value preferred stock (of which no shares are outstanding), with respect to which our Board may fix the series and terms of issuance, and 400 million shares of $1 par value voting common stock.

From time to time, our Board authorizes the repurchase of shares of our outstanding common stock. Repurchased shares may be reissued under our long-term incentive plan or used for other corporate purposes. In 2018, we repurchased approximately 4.0 million shares of our common stock at an aggregate cost of $392.9 million. In 2017, we repurchased approximately 1.5 million shares of our common stock at an aggregate cost of $129.7 million.

In April 2017, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $650 million, exclusive of any fees, commissions or other expenses related to such purchases, in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased. Shares of our common stock in the aggregate amount of $232.4 million and $625.2 million as of December 29, 2018 and December 30, 2017, respectively, remained authorized for repurchase under this Board authorization.

We fund a portion of our employee-related expenses using shares of our common stock held in treasury. We record net gains or losses associated with our use of treasury shares to retained earnings.

The changes in "Accumulated other comprehensive loss" (net of tax) for 2018 and 2017 were as follows:

(In millions)	Foreign Currency Translation			Pension and Other Postretirement Benefits			Cash Flow Hedges			Total


Balance as of December 31, 2016	$	(212.6	)	$	(540.3	)	$	1.0		$	(751.9	)
Other comprehensive income (loss) before reclassifications, net of tax		56.4			(3.0	)		(2.2	)		51.2
Reclassifications to net income, net of tax		–			19.3			.9			20.2

Net current-period other comprehensive income (loss), net of tax		56.4			16.3			(1.3	)		71.4

Balance as of December 30, 2017	$	(156.2	)	$	(524.0	)	$	(.3	)	$	(680.5	)
Other comprehensive (loss) income before reclassifications, net of tax		(91.2	)		(4.1	)		1.1			(94.2	)
Reclassifications to net income, net of tax		–			93.8			(1.1	)		92.7

Net current-period other comprehensive (loss) income, net of tax		(91.2	)		89.7			–			(1.5	)

Balance as of December 29, 2018	$	(247.4	)	$	(434.3	)	$	(.3	)	$	(682.0	)

The amounts reclassified from "Accumulated other comprehensive loss" to increase (decrease) net income were as follows:

(In millions)	2018			2017			2016			Affected Line Item in the Statements Where Net Income is Presented


Cash flow hedges:
Foreign exchange contracts	$	1.3		$	.2		$	(3.0	)	Cost of products sold
Commodity contracts		.1			.2			(.7	)	Cost of products sold
Interest rate contracts		–			(1.8	)		(.1	)	Interest expense

		1.4			(1.4	)		(3.8	)	Total before tax
		(.3	)		.5			1.0		Provision for income taxes

		1.1			(.9	)		(2.8	)	Net of tax

Pension and other postretirement benefits		(121.4	)		(28.2	)		(66.8	)	Other non-operating expense
		27.6			8.9			22.6		Provision for income taxes

		(93.8	)		(19.3	)		(44.2	)	Net of tax

Total reclassifications for the period	$	(92.7	)	$	(20.2	)	$	(47.0	)	Total, net of tax

The following table sets forth the income tax expense (benefit) allocated to each component of other comprehensive (loss) income:

(In millions)	2018			2017			2016


Foreign currency translation:
Translation (loss) gain	$	(9.1	)	$	(25.1	)	$	(3.3	)
Pension and other postretirement benefits:
Net loss recognized from actuarial gain/loss and prior service cost/credit		(2.4	)		.5			(24.2	)
Reclassifications to net income		27.6			8.9			22.6
Cash flow hedges:
Gains (losses) recognized on cash flow hedges		.3			(.6	)		.1
Reclassifications to net income		(.3	)		.5			1.0

Income tax expense (benefit) related to items of other comprehensive (loss) income	$	16.1		$	(15.8	)	$	(3.8	)

We grant our annual stock-based compensation awards to eligible employees in February and non-employee directors in May. Certain awards granted to retirement-eligible employees vest in full upon retirement; awards to these employees are accounted for as fully vested on the date of grant.

In April 2017, our shareholders approved our 2017 Incentive Award Plan (the "Equity Plan") to replace our Amended and Restated Stock Option and Incentive Plan. The Equity Plan, a long-term incentive plan for eligible employees and non-employee directors, allows us to grant stock-based compensation awards–including stock options, RSUs, PUs, and MSUs–or a combination of these and other awards. Under the Equity Plan, 5.4 million shares are available for issuance, and each full value award is counted as 1.5 shares for purposes of the number of shares authorized for issuance. Full value awards include RSUs, PUs, and MSUs.

Stock-based compensation expense and the related recognized tax benefit were as follows:

This expense was included in "Marketing, general and administrative expense" in the Consolidated Statements of Income.

As of December 29, 2018, we had approximately $39 million of unrecognized compensation expense related to unvested stock-based awards, which is expected to be recognized over the remaining weighted-average requisite service period of approximately two years.

Stock options granted to employees may be granted at no less than 100% of the fair market value of our common stock on the date of the grant and generally vest ratably over a four-year period. Options expire ten years from the date of grant.

The following assumptions are used in estimating the fair value of granted stock options:

Risk-free interest rate is based on the 52-week average of the Treasury-Bond rate that has a term corresponding to the expected option term.

Expected stock price volatility represents an average of the implied and historical volatility.

Expected dividend yield is based on the current annual dividend divided by the 12-month average of our monthly stock price prior to grant.

Expected option term is determined based on historical experience under our stock option and incentive plans.

The weighted-average grant date fair value per share for stock options granted in 2016 was $14.17. No stock options were granted in fiscal years 2018 or 2017.

The total intrinsic value of stock options exercised was $2.7 million in 2018, $26.8 million in 2017, and $31.7 million in 2016. We received approximately $1 million in 2018, $22 million in 2017, and $71 million in 2016 from the exercise of stock options. The tax benefit associated with these exercised options was $.6 million in 2018, $10.1 million in 2017, and $11.3 million in 2016. The intrinsic value of a stock option is based on the amount by which the market value of the underlying stock exceeds the exercise price of the option.

PUs are performance-based awards granted to eligible employees under our equity plans. PUs are payable in shares of our common stock at the end of a three-year cliff vesting period provided that certain performance objectives are achieved at the end of the period. Over the performance period, the estimated number of shares of our common stock issuable upon vesting is adjusted upward or downward based upon the probability of the achievement of the performance objectives established for the award. The actual number of shares issued can range from 0% to 200% of the target shares at the time of grant. The weighted-average grant date fair value for PUs was $120.25, $82.15, and $68.04 in 2018, 2017, and 2016, respectively.

The fair value of vested PUs was $11.9 million in 2018, $11.2 million in 2017, and $13.8 million in 2016.

MSUs are performance-based awards granted to eligible employees under our equity plans. MSUs are payable in shares of our common stock over a four-year period provided that the performance objective is achieved as of the end of each vesting period. MSUs accrue dividend equivalents during the vesting period, which are earned and paid only at vesting provided that, at a minimum, threshold performance is achieved. The number of shares earned is based upon our absolute total shareholder return at each vesting date and can range from 0% to 200% of the target amount of MSUs subject to vesting. Each of the four vesting periods represents one tranche of MSUs and the fair value of each of these four tranches was determined using the Monte-Carlo simulation model, which utilizes multiple input variables, including expected stock price volatility and other assumptions, to estimate the probability of achieving the performance objective established for the award. The weighted-average grant date fair value for MSUs was $117.75, $91.40, and $72.93 in 2018, 2017, and 2016, respectively.

The fair value of vested MSUs was $24.0 million in 2018, $19.3 million in 2017, and $12.4 million in 2016.

RSUs are service-based awards granted to eligible employees under our equity plans, which generally vest ratably over a period of four years for employees. Prior to 2017, RSUs granted to non-employee directors under our equity plans vested ratably over a period of three years. Beginning in 2017, RSUs granted to non-employee directors generally vest over a period of one year. The vesting of RSUs is subject to continued service through the applicable vesting date. If that condition is not met, unvested RSUs are generally forfeited. The weighted-average grant date fair value for RSUs was $106.44, $82.77, and $67.66 in 2018, 2017, and 2016, respectively.

The fair value of vested RSUs was $5.1 million, $2.7 million, and $5.3 million in 2018, 2017, and 2016, respectively.

LTI Units are granted to eligible employees under our long-term incentive unit plan. LTI Units are service-based awards that generally vest ratably over a four-year period. The settlement value equals the number of vested LTI Units multiplied by the average of the high and low market prices of our common stock on the vesting date. The compensation expense related to these awards is amortized on a straight-line basis and the fair value is remeasured using the estimated percentage of units expected to be earned multiplied by the average of the high and low market prices of our common stock at each quarter-end.

We also grant cash-based awards in the form of performance and market-leveraged LTI Units to eligible employees. Performance LTI Units are payable in cash at the end of a three-year cliff vesting period provided that certain performance objectives are achieved at the end of the performance period. Market-leveraged LTI Units are payable in cash and vest ratably over a period of four years. The number of performance and market-leveraged LTI Units earned at vesting is adjusted upward or downward based upon the probability of achieving the performance objectives established for the respective award and the actual number of units issued can range from 0% to 200% of the target units subject to vesting. The performance and market-leveraged LTI Units are remeasured using the estimated percentage of units expected to be earned multiplied by the average of the high and low market prices of our common stock at each quarter-end over their respective performance periods. The compensation expense related to performance LTI Units is amortized on a straight-line basis over their respective performance periods. The compensation expense related to market-leveraged LTI Units is amortized on a graded-vesting basis over their respective performance periods.

The compensation expense related to LTI Units was $12.4 million in 2018, $36.6 million in 2017, and $23.8 million in 2016. This expense was included in "Marketing, general and administrative expense" in the Consolidated Statements of Income. The total recognized tax benefit related to LTI Units was $2.9 million in 2018, $8.3 million in 2017, and $7.8 million in 2016.

We have plans that provide eligible employees with severance in the event of an involuntary termination. We calculate severance using the applicable benefit formulas under the respective plans. Accordingly, we record restructuring charges from qualifying cost reduction actions for severance and other exit costs (including asset impairment charges and lease and other contract cancellation costs) when they are probable and estimable. In the absence of a plan or established local practice in overseas jurisdictions, liabilities for restructuring charges are recognized when incurred.

In April 2018, we approved a restructuring plan (the "2018 Plan") associated with the consolidation of the European footprint of our LGM reportable segment, which is expected to result in a headcount reduction of approximately 400 positions related to the closure of a manufacturing facility. This reduction is expected to be partially offset by headcount additions in other locations, resulting in a net reduction of approximately 150 positions. During fiscal year 2018, we recorded $55.2 million in restructuring charges, net of reversals, related to the 2018 Plan. These charges consisted of severance and related costs for the reduction of approximately 345 positions, as well as asset impairment charges. We expect the 2018 Plan to be substantially complete by the end of 2019.

During fiscal year 2016, we recorded $20.9 million in restructuring charges, net of reversals, related to our 2015/2016 Actions. These charges consisted of severance and related costs for the reduction of approximately 440 positions, lease cancellation costs, and asset impairment charges.

The activities and related charges and payments for the 2015/2016 Actions were substantially completed in 2018.

Accruals for severance and related costs and lease cancellation costs were included in "Other accrued liabilities" in the Consolidated Balance Sheets. Asset impairment charges were based on the estimated market value of the assets, less selling costs, if applicable.

Restructuring charges were included in "Other expense, net" in the Consolidated Statements of Income.

(In millions)	Accrual at December 30, 2017		Charges, Net of Reversals		Cash Payments			Non-cash Impairment			Foreign Currency Translation			Accrual at December 29, 2018


2018/2019 Actions
Severance and related costs	$	–	$	51.8	$	(9.8	)	$	–		$	(1.3	)	$	40.7
Asset impairment charges		–		7.6		–			(7.6	)		–			–
2015/2016 Actions
Severance and related costs		4.3		11.2		(15.2	)		–			–			.3
Lease cancellation costs		.6		.8		(1.0	)		–			–			.4
Asset impairment charges		–		2.3		–			(2.3	)		–			–

Total	$	4.9	$	73.7	$	(26.0	)	$	(9.9	)	$	(1.3	)	$	41.4

The table below shows the total amount of restructuring charges incurred by reportable segment and Corporate:

(In millions)	2018			2017			2016


Current:
U.S. federal tax	$	(19.7	)	$	47.0		$	10.1
State taxes		.8			.2			.6
International taxes		134.3			111.0			77.3

		115.4			158.2			88.0

Deferred:
U.S. federal tax		(6.3	)		134.8			64.4
State taxes		2.3			(3.7	)		(3.0	)
International taxes		(26.0	)		18.4			7.0

		(30.0	)		149.5			68.4

Provision for income taxes	$	85.4		$	307.7		$	156.4

The principal items accounting for the difference between taxes computed at the U.S. federal statutory rate and taxes recorded were as follows:

(In millions)	2018			2017			2016


Computed tax provision at U.S. federal statutory rate	$	116.5		$	206.7		$	167.0
Increase (decrease) in taxes resulting from:
State taxes, net of federal tax benefit		3.9			(3.2	)		2.2
Tax Cuts and Jobs Act(1)		(34.7	)		172.0			–
Foreign earnings taxed at different rates(2)		13.0			(40.2	)		27.0
Excess tax benefits associated with stock-based payments(3)		(7.7	)		(16.0	)		–
Valuation allowance		10.7			(1.4	)		(11.9	)
Corporate-owned life insurance		(3.8	)		(6.7	)		(4.3	)
U.S. federal research and development tax credits		(6.1	)		(4.9	)		(2.9	)
Tax contingencies and audit settlements		(11.9	)		(1.9	)		(20.7	)
Other items, net		5.5			3.3			–

Provision for income taxes	$	85.4		$	307.7		$	156.4

(1): During 2018 and 2017, we recognized a net tax benefit of $34.7 million and a net tax charge of $172 million, respectively, as a result of the TCJA. These amounts included the direct impacts of the TCJA following the guidance of SAB 118, including items that would otherwise be separately disclosed as state taxes, net of federal tax benefit, tax effects of foreign earnings taxed at different rates, tax contingencies and audit settlements, and other items, net.
(2): Included in 2018 are certain U.S. international tax provisions imposed by the TCJA; all years included foreign earnings taxed in the U.S., net of credits.
(3): During 2018 and 2017, we recognized tax benefits of $7.7 million and $16 million as a result of our adoption in 2017 of the accounting guidance update related to stock-based payments. We expect future excess tax benefits to vary based on our future stock-based payments. These excess tax benefits may cause variability in our effective tax rate as they can fluctuate based on vesting and exercise activity, as well as our stock price.

The effective tax rate was 15.4%, 52.2%, and 32.8% for fiscal years 2018, 2017, and 2016, respectively.

The 2018 effective tax rate included measurement period adjustments to our 2017 provisional amount related to the TCJA in accordance with guidance provided under SEC Staff Accounting Bulletin No. 118 ("SAB 118"). In 2018, we adjusted our 2017 provisional amount by recognizing a net tax benefit of $34.7 million. This amount primarily included: (i) $39.6 million tax benefit related to the remeasurement of the net deferred tax asset from cash contributions to the ADPP and realized foreign currency loss, both of which resulted from our decision to accelerate the related deductions on our 2017 U.S. federal income tax return; (ii) $3.6 million of tax charges for changes in our indefinite reinvestment assertions related to our investments in certain foreign subsidiaries after information required to make such determinations was obtained; (iii) $9.5 million of tax charge for adjustments made to the one-time transition tax, primarily due to a change in our filing position and to reflect regulatory and administrative guidance subsequently issued by the Internal Revenue Service ("IRS") and certain state taxing authorities; and (iv) $9.4 million of tax benefit from releasing a previously recorded uncertain tax position after the position was not taken on our 2017 U.S. federal income tax return.

The 2018 effective tax rate also included net tax charges related to: (i) the effects of certain U.S. international tax provisions imposed by the TCJA, including $16 million of tax charge on Global Intangible Low-taxed Income ("GILTI") and $9 million of tax charge on Base Erosion Antiabuse Tax ("BEAT") partially offset by $2 million of tax benefit on Foreign Derived Intangible Income ("FDII"); (ii) $7.9 million of tax charges for foreign withholding taxes on our current year earnings; (iii) $8.8 million of tax benefit, including previously accrued interest and penalties, primarily from our changes in our judgment about tax filing positions due to the effective settlement of our German tax audit for tax years 2006-2010; and (iv) $8 million of tax benefit from decreases in certain tax reserves, including interest and penalties, as a result of closing tax years.

Additionally, the 2018 effective tax rate was not significantly impacted by the $10.7 million increase in valuation allowance primarily due to the offsetting effects from changes in deferred taxes and uncertain tax positions.

During 2018, after our adoption of the accounting guidance update related to intra-entity transfers of assets other than inventory, certain foreign owned intellectual property was transferred between our foreign subsidiaries. Refer to Note 1, "Summary of Significant Accounting Policies," for more information. Accordingly, we recognized a net discrete tax benefit of $31 million primarily due to the recognition of a deferred tax asset in a higher tax rate jurisdiction, partially offset by a taxable gain recognized in a lower effective tax rate jurisdiction.

We assess the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use existing deferred tax assets. On the basis of our assessment, we record valuation allowances only with respect to the portion of the deferred tax asset that is more likely than not to be realized. Our assessment of the future realizability of our deferred tax assets relies heavily on our forecasted earnings in certain jurisdictions, and such forecasted

earnings are determined by the manner in which we operate our business. Any changes to our operations may affect our assessment of deferred tax assets considered realizable if the positive evidence no longer outweighs the negative evidence.

The TCJA enacted in the U.S. in December 2017 significantly changed U.S. corporate income taxation by, among other things, reducing the federal corporate income tax rates to 21%, implementing a modified territorial tax system prospectively by providing a dividend received deduction on certain dividends from our foreign subsidiaries, loss of domestic manufacturing deductions, and limitations on the deductibility of our executive compensation and interest expense, and imposing a one-time transition tax through a deemed repatriation of accumulated untaxed earnings and profits of foreign subsidiaries.

In 2017, we included a provisional amount of $172 million as the estimated impact of the TCJA in our results for the fourth quarter and full year 2017. This provisional amount included expenses of $147 million related to the estimated transition tax, $49.2 million resulting from the estimated remeasurement of net U.S. deferred tax assets at the lower corporate income tax rate, a $9.3 million reserve related to potential uncertainties of our accumulated tax attributes that were used in our estimated transition tax calculation, $5.3 million from the estimated reduction of previously recognized U.S. deferred tax assets that we no longer anticipated to benefit from due to changes in the future deductibility of executive compensation, partially offset by a net benefit of $38.8 million, primarily from the reversal of the deferred tax liability that we previously recorded for future tax costs associated with repatriations of certain foreign earnings and profits that we considered not to be indefinitely reinvested.

As of December 29, 2018, we have completed our accounting for the income tax effects of the TCJA following the guidance of SAB 118. Specifically, we have adjusted our provisional amount previously recorded primarily related to (i) the transition tax, reflecting subsequent regulatory and administrative guidance and the finalization of our foreign earnings and profits as well as taxes, (ii) the remeasurement of deferred taxes as a result of our decision to accelerate certain deductions in conjunction with the completion of our 2017 U.S. federal income tax return; and (iii) an incremental accrual for foreign withholding taxes associated with changes in our indefinite reinvestment assertions after information required to make such determination was obtained.

The FASB guidance states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred. We have made an accounting policy election to account for taxes on GILTI as period costs.

Additionally, we have reevaluated our previous indefinite reinvestment assertions and, as of December 29, 2018, we no longer considered any of our foreign earnings in our foreign subsidiaries to be indefinitely reinvested. We recorded a tax charge of $3.6 million as a result of this change in assertion, which was included in our adjustment to our TCJA provisional amount.

Deferred income taxes reflect the temporary differences between the amounts at which assets and liabilities are recorded for financial reporting purposes and the amounts utilized for tax purposes. The primary components of the temporary differences that gave rise to our deferred tax assets and liabilities were as follows:

(In millions)	2018			2017


Accrued expenses not currently deductible	$	18.4		$	19.9
Net operating losses		166.4			185.9
Tax credit carryforwards		69.0			14.0
Stock-based compensation		12.4			18.0
Pension and other postretirement benefits		81.3			140.9
Inventory reserves		6.7			6.5
Unrealized foreign currency losses(1)		–			14.9
Other assets		11.8			17.3
Valuation allowance		(71.8	)		(63.4	)

Total deferred tax assets(2)		294.2			354.0

Depreciation and amortization		(38.7	)		(95.3	)
Repatriation accrual		(21.3	)		(27.7	)
Foreign operating loss recapture		(56.5	)		(65.9	)
Other liabilities		(9.5	)		(8.8	)

Total deferred tax liabilities(2)		(126.0	)		(197.7	)

Total net deferred tax assets	$	168.2		$	156.3

Net operating loss carryforwards of foreign subsidiaries at December 29, 2018 and December 30, 2017 were $538.4 million and $633.7 million, respectively. Tax credit carryforwards of both domestic and foreign subsidiaries at December 29, 2018 and December 30, 2017 totaled $69 million and $14 million, respectively. If unused, foreign net operating losses and tax credit carryforwards will expire as follows:

Based on current projections, certain indefinite-lived foreign net operating losses may take decades to be fully utilized.

At December 29, 2018, we had net operating loss carryforwards in certain state jurisdictions of $634.6 million before tax effect. Based on our current ability to generate state taxable income, it is more likely than not that the majority of these carryforwards will not be realized before they expire. Accordingly, a valuation allowance has been recorded on $591.3 million of the carryforwards.

As of December 29, 2018, our provision for income taxes did not materially benefit from applicable tax holidays in foreign jurisdictions.

As of December 29, 2018, our unrecognized tax benefits totaled $80.8 million, $72.2 million of which, if recognized, would reduce our annual effective income tax rate. As of December 30, 2017, our unrecognized tax benefits totaled $108.7 million, $83.9 million of which, if recognized, would reduce our annual effective income tax rate.

Where applicable, we record potential accrued interest and penalties related to unrecognized tax benefits from our global operations in income tax expense. As a result, we recognized $.5 million of tax charge, $1.5 million of tax charge, and $3.1 million of tax benefit in the Consolidated Statements of Income in 2018, 2017, and 2016, respectively. We have accrued $25.0 million and $25.8 million for interest and penalties, net of tax benefit, in the Consolidated Balance Sheets at December 29, 2018 and December 30, 2017, respectively.

A reconciliation of the beginning and ending amounts of unrecognized tax benefits is set forth below:

The amount of income taxes we pay is subject to ongoing audits by taxing jurisdictions around the world. Our estimate of the potential outcome of any uncertain tax issue is subject to our assessment of the relevant risks, facts, and circumstances existing at the time. We believe that we have adequately provided for reasonably foreseeable outcomes related to these matters. However, our future results may include favorable or unfavorable adjustments to our estimated tax liabilities in the period the assessments are made or resolved, which may impact our effective tax rate. As of the date the 2018 Consolidated Financial Statements are being issued, we and our U.S. subsidiaries have completed the IRS' Compliance Assurance Process Program through 2016. We are subject to routine tax examinations in other jurisdictions. With some exceptions, we and our subsidiaries are no longer subject to income tax examinations by tax authorities for years prior to 2007.

It is reasonably possible that, during the next 12 months, we may realize a decrease in our uncertain tax positions, including interest and penalties, of approximately $14 million, primarily as a result of audit settlements and closing tax years.

Intersegment sales are recorded at or near market prices and are eliminated in determining consolidated sales. We evaluate performance based on income from operations before interest expense and taxes. General corporate expenses are excluded from the computation of income from operations for the segments.

We do not disclose total assets by reportable segment since we neither generate nor review such information internally. As our reporting structure is neither organized nor reviewed internally by country, results by individual country are not provided.

Disaggregated revenue information is set forth below in the manner that best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. Revenue from our LGM reportable segment is attributed to geographic areas based on the location from which products are shipped. Revenue from our RBIS reportable segment is shown by product group.

(In millions)	2018		2017		2016


Net sales to unaffiliated customers
Label and Graphic Materials:
U.S.	$	1,256.0	$	1,198.4	$	1,161.0
Europe		1,851.3		1,689.3		1,514.3
Asia		1,081.2		1,002.6		928.9
Latin America		367.8		357.0		331.6
Other international		294.8		264.4		251.5

Total Label and Graphic Materials		4,851.1		4,511.7		4,187.3

Retail Branding and Information Solutions:
Apparel		1,441.7		1,352.0		1,276.7
Printer Solutions		171.5		159.2		168.7

Total Retail Branding and Information Solutions		1,613.2		1,511.2		1,445.4

Industrial and Healthcare Materials		694.7		590.9		453.8

Net sales to unaffiliated customers	$	7,159.0	$	6,613.8	$	6,086.5

Revenue by geographic area is set forth below. Revenue is attributed to geographic areas based on the location from which the product is shipped.

Net sales to unaffiliated customers in Asia included sales in China (including Hong Kong) of $1.43 billion in 2018, $1.3 billion in 2017, and $1.14 billion in 2016.

(In millions)	2018			2017			2016


Intersegment sales
Label and Graphic Materials	$	78.7		$	64.1		$	63.4
Retail Branding and Information Solutions		4.7			3.2			2.9
Industrial and Healthcare Materials		8.8			7.7			7.2

Intersegment sales	$	92.2		$	75.0		$	73.5

Income before taxes
Label and Graphic Materials	$	568.2		$	577.4		$	522.0
Retail Branding and Information Solutions		170.4			126.7			105.0
Industrial and Healthcare Materials		62.9			52.6			56.1
Corporate expense		(83.4	)		(86.2	)		(92.9	)
Interest expense		(58.5	)		(63.0	)		(59.9	)
Other non-operating expense		(104.8	)		(18.0	)		(53.2	)

Income before taxes	$	554.8		$	589.5		$	477.1

Capital expenditures
Label and Graphic Materials	$	151.5		$	125.5		$	118.8
Retail Branding and Information Solutions		57.1			48.8			50.9
Industrial and Healthcare Materials		19.3			19.5			7.2

Capital expenditures	$	227.9		$	193.8		$	176.9

Depreciation and amortization expense
Label and Graphic Materials	$	104.7		$	102.3		$	103.1
Retail Branding and Information Solutions		49.0			56.4			64.3
Industrial and Healthcare Materials		27.3			20.0			12.7

Depreciation and amortization expense	$	181.0		$	178.7		$	180.1

Other expense, net by reportable segment
Label and Graphic Materials	$	61.8		$	14.5		$	13.0
Retail Branding and Information Solutions		11.4			18.1			9.8
Industrial and Healthcare Materials		(1.0	)		3.7			1.9
Corporate		(2.3	)		.2			(.9	)

Other expense, net	$	69.9		$	36.5		$	23.8

Other expense, net by type
Restructuring charges:
Severance and related costs	$	63.0		$	31.2		$	14.7
Asset impairment charges and lease cancellation costs		10.7			2.2			5.2
Other items:
Argentine peso remeasurement transition loss		3.4			–			–
Other restructuring-related charge		.5			–			–
Transaction costs		–			5.2			5.0
Reversal of acquisition-related contingent consideration		(5.0	)		–			–
Net gain on sales of assets		(2.7	)		(2.1	)		(1.1	)

Other expense, net	$	69.9		$	36.5		$	23.8

Property, plant and equipment, net, in our U.S. and international operations were as follows:

Major classes of property, plant and equipment, stated at cost, at year-end were as follows:

Software amortization expense was $20.2 million in 2018, $29.3 million in 2017, and $37.9 million in 2016.

In October 2016, we acquired a 22.6% interest in PragmatIC Printing Limited ("PragmatIC"), a company that develops flexible electronics technology. PragmatIC's primary assets are intangible assets related to its technology. We used the equity method to account for this investment. The carrying value of this investment was $6.7 million and $9.1 million as of December 29, 2018 and December 30, 2017, respectively, and was included in "Other assets" in the Consolidated Balance Sheets.

Research and development expense, which is included in "Marketing, general and administrative expense" in the Consolidated Statements of Income, was as follows:

Gains and losses resulting from foreign currency transactions are included in income in the period incurred. Transactions in foreign currencies (including receivables, payables and loans denominated in currencies other than the functional currency), including hedging impacts, decreased net income by $13.4 million, $4.1 million, and $1.6 million in 2018, 2017, and 2016, respectively.

Deferred revenue primarily relates to constrained variable consideration on supply agreements for sales of products, as well as to payments received in advance of performance under a contract. Deferred revenue is recognized as revenue as or when we perform under a contract.

The following table shows the amounts and balance sheet locations of deferred revenue as of December 29, 2018 and December 30, 2017:

Revenue recognized from amounts included in deferred revenue as of December 30, 2017 was $12.2 million in 2018, which was included in "Net sales" in the Consolidated Statements of Income.

(In millions, except per share data)	First Quarter		Second Quarter		Third Quarter		Fourth Quarter


2018
Net sales	$	1,776.4	$	1,854.2	$	1,759.7	$	1,768.7
Gross profit		483.4		501.4		459.2		471.5
Net income		125.2		95.6		149.5		97.1
Net income per common share		1.42		1.09		1.71		1.13
Net income per common share, assuming dilution		1.40		1.07		1.69		1.11

2017
Net sales	$	1,572.1	$	1,626.9	$	1,679.5	$	1,735.3
Gross profit		442.4		452.6		451.6		465.6
Net income (loss)(1)		112.2		120.9		108.3		(59.6	)
Net income (loss) per common share		1.27		1.37		1.23		(.68	)
Net income (loss) per common share, assuming dilution		1.25		1.34		1.20		(.66	)

(In millions)	First Quarter			Second Quarter			Third Quarter			Fourth Quarter


2018
Restructuring charges:
Severance and related costs, net of reversals	$	4.3		$	58.8		$	(7.1	)	$	7.0
Asset impairment charges and lease cancellation costs		8.4			.6			.7			1.0
Other items:
Argentine peso remeasurement transition loss		–			–			3.4			–
Other restructuring-related charge		.5			–			–			–
Reversal of acquisition-related contingent consideration		–			–			–			(5.0	)
Net gain on sales of assets		(.4	)		(2.3	)		–			–

Other expense (income), net	$	12.8		$	57.1		$	(3.0	)	$	3.0

2017
Restructuring charges:
Severance and related costs	$	5.7		$	7.3		$	8.7		$	9.5
Asset impairment charges and lease cancellation costs		–			.3			1.8			.1
Other items:
Net gain on sales of assets		–			–			–			(2.1	)
Transaction costs		.8			2.6			.3			1.5

Other expense, net	$	6.5		$	10.2		$	10.8		$	9.0

The consolidated financial statements and accompanying information are the responsibility of and were prepared by management. The statements were prepared in conformity with accounting principles generally accepted in the United States of America and, as such, include amounts that are based on management's best estimates and judgments.

Oversight of management's financial reporting and internal accounting control responsibilities is exercised by our Board of Directors, through its Audit and Finance Committee, which is comprised solely of independent directors. The Committee meets periodically with financial management, internal auditors and our independent registered public accounting firm to obtain reasonable assurance that each is meeting its responsibilities and to discuss matters concerning auditing, internal accounting control and financial reporting. The independent registered public accounting firm and our internal audit department have free access to, and periodically meet with, the Audit and Finance Committee without management present.

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as that term is defined in Exchange Act Rule 13a-15(f) or 15(d)-15(f). Under the supervision and with the participation of management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of internal control over financial reporting based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control – Integrated Framework (2013), management has concluded that internal control over financial reporting was effective as of December 29, 2018. Management's assessment of the effectiveness of internal control over financial reporting as of December 29, 2018 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report included herein.

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Avery Dennison Corporation and its subsidiaries (the "Company") as of December 29, 2018 and December 30, 2017, and the related consolidated statements of income, comprehensive income, shareholders' equity and cash flows for each of the three years in the period ended December 29, 2018 , including the related notes (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of December 29, 2018, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO").

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 29, 2018 and December 30, 2017, and the results of its operations and its cash flows for each of the three years in the period ended December 29, 2018 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 29, 2018, based on criteria established in Internal Control – Integrated Framework (2013) issued by the COSO.

As discussed in Note 1 to the consolidated financial statements, the Company changed the manner in which it accounts for net periodic pension and postretirement benefit costs in 2018.

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express opinions on the Company's consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

We have served as the Company's auditor since at least 1960, which were the Company's first financial statements subject to SEC reporting requirements. We have not been able to determine the specific year we began serving as auditor of the Company or a predecessor company.

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
(888) 682-5999
(720) 864-4993 (international)
(855) 627-5080 (hearing impaired)
https://investor.broadridge.com

Our Annual Meeting of Stockholders will be held at 1:30 p.m. Pacific Time on April 25, 2019 at 207 Goode Avenue, Glendale, California 91203.

Shareholders of record may reinvest their cash dividends in additional shares of our common stock at market price. Investors may also invest optional cash payments of up to $12,500 per month in our common stock at market price. Investors not yet participating in the program, as well as brokers and custodians who hold our common stock on behalf of clients, may obtain a copy of the program by contacting Broadridge Corporate Issuer Solutions, Inc.

Shareholders may receive their quarterly dividend payments by direct deposit into their checking or savings accounts. For more information, contact Broadridge Corporate Issuer Solutions, Inc.

We are including, as Exhibits 31.1 and 31.2 to our Annual Report on Form 10-K for fiscal year 2018 filed with the Securities and Exchange Commission ("SEC"), certificates of our Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. We submitted to the New York Stock Exchange ("NYSE") an unqualified annual written affirmation, along with the Chief Executive Officer's certificate that he is not aware of any violation by the Company of NYSE's corporate governance listing standards, on April 27, 2018.

A copy of our Annual Report on Form 10-K, as filed with the SEC, will be furnished to shareholders and interested investors free of charge upon written request to our Corporate Secretary. Copies are also available on our investor website at www.investors.averydennison.com.

Avery Dennison Corporation
207 Goode Avenue
Glendale, California 91203
Phone: (626) 304-2000

	12/31/2013		12/31/2014		12/31/2015		12/31/2016		12/31/2017		12/31/2018


Avery Dennison Corporation	$	100.00	$	106.03	$	128.63	$	143.13	$	220.86	$	170.81
S&P 500 Index		100.00		110.79		109.98		120.00		141.29		132.19
Market Basket (Weighted Average)(2)		100.00		112.10		109.65		130.43		160.25		139.53
Market Basket (Median)		100.00		110.93		101.68		118.90		144.67		121.00


Non-GAAP Financial Measures		4
Overview and Outlook		4
Analysis of Results of Operations		6
Results of Operations by Reportable Segment		8
Financial Condition		9
Critical Accounting Estimates		13
Recent Accounting Requirements		15
Market-Sensitive Instruments and Risk Management		15

	Amount (in millions)


Customer relationships	$	70.9	16
Patents and other acquired technology		31.9	9
Trade names and trademarks		4.2	6

	Amount (in millions)


Customer relationships	$	26.1	15
Patents and other acquired technology		2.5	4

	2018						2017

(In millions)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount

Customer relationships	$	322.2	$	231.8	$	90.4	$	329.2	$	226.4	$	102.8
Patents and other acquired technology		84.0		56.8		27.2		86.9		51.3		35.6
Trade names and trademarks		27.0		21.7		5.3		27.7		21.0		6.7
Other intangibles		11.9		11.9		–		12.0		12.0		–

Total	$	445.1	$	322.2	$	122.9	$	455.8	$	310.7	$	145.1




Reported sales change	8	%	9	%
Foreign currency translation	(1	)	(1	)

Sales change ex. currency	7	%	8	%
Acquisitions	(1	)	(4	)

Organic sales change	6	%	4	%

(In millions)	2018			2017			2016


Net sales including intersegment sales	$	4,929.8		$	4,575.8		$	4,250.7
Less intersegment sales		(78.7	)		(64.1	)		(63.4	)

Net sales	$	4,851.1		$	4,511.7		$	4,187.3
Operating income(1)		568.2			577.4			522.0

(1) Included charges associated with restructuring in all years, Argentine peso remeasurement transition loss, other restructuring-related charge and loss on sale of assets in 2018, gains on sales of assets in 2017, and transaction costs in 2017 and 2016.	$	61.8		$	14.5		$	13.0

(In millions)	2018			2017			2016


Net sales including intersegment sales	$	1,617.9		$	1,514.4		$	1,448.3
Less intersegment sales		(4.7	)		(3.2	)		(2.9	)

Net sales	$	1,613.2		$	1,511.2		$	1,445.4
Operating income(1)		170.4			126.7			105.0

(1) Included charges associated with restructuring and net gains on sales of assets in all years and transaction costs related to sale of product line in 2017 and 2016.	$	11.4		$	18.1		$	9.8

(In millions)	2018			2017			2016


Net sales including intersegment sales	$	703.5		$	598.6		$	461.0
Less intersegment sales		(8.8	)		(7.7	)		(7.2	)

Net sales	$	694.7		$	590.9		$	453.8
Operating income(1)		62.9			52.6			56.1

(1) Included charges associated with restructuring in all years, transaction costs in 2017 and 2016, and reversal of acquisition-related contingent consideration in 2018.	$	(1.0	)	$	3.7		$	1.9

(In millions)	2018			2017			2016


Net change in borrowings and repayments of debt and capital leases	$	(84.0	)	$	(343.0	)	$	232.2
Additional long-term borrowings		493.3			542.9			–
Dividends paid		(175.0	)		(155.5	)		(142.5	)
Share repurchases		(392.9	)		(129.7	)		(262.4	)
Net (tax withholding) proceeds related to stock-based compensation		(32.2	)		1.4			66.5
Payments of contingent consideration		(17.3	)		–			–

Net cash used in financing activities	$	(208.1	)	$	(83.9	)	$	(106.2	)

	Payments Due by Period

(In millions)	Total		2019		2020		2021		2022		2023		Thereafter

Short-term borrowings	$	176.5	$	176.5	$	–	$	–	$	–	$	–	$	–
Long-term debt		1,782.3		14.4		265.0		–		–		250.0		1,252.9
Payments related to long-term capital leases		30.5		5.9		5.4		5.2		4.8		4.7		4.5
Interest on long-term debt		482.2		65.7		55.6		51.1		51.1		45.2		213.5
Operating leases		184.8		47.7		38.9		29.4		18.8		12.9		37.1

Total contractual obligations	$	2,656.3	$	310.2	$	364.9	$	85.7	$	74.7	$	312.8	$	1,508.0

	2017							2016

(In millions)	As Previously Reported		Reclassi- fication			As Reclassified		As Previously Reported		Reclassi- fication			As Reclassified

Marketing, general and administrative expense	$	1,123.2	$	(18.0	)	$	1,105.2	$	1,097.5	$	(11.8	)	$	1,085.7
Other expense, net		36.5		–			36.5		65.2		(41.4	)		23.8
Other non-operating expense		–		18.0			18.0		–		53.2			53.2

Year	(In millions)


2019 (classified as current)	$	19.0
2020		269.0
2021		3.9
2022		3.5
2023		253.3
2024 and thereafter		1,257.1

	Asset					Liability

(In millions)	Balance Sheet Location	2018		2017		Balance Sheet Location	2018		2017

Foreign exchange contracts	Other current assets	$	.5	$	.4	Other accrued liabilities	$	.8	$	.6
Commodity contracts	Other current assets	.1		–

		$	.6	$	.4		$	.8	$	.6

	Level 3 Assets

(In millions)	Insurance Contracts

Balance at December 30, 2017	$	35.7
Net realized and unrealized gain		1.0
Purchases		5.9
Settlements		(5.0	)
Transfer		.1
Impact of changes in foreign currency exchange rates		(.8	)

Balance at December 29, 2018	$	36.9

													U.S. Postretirement

	Pension Benefits												Health Benefits
	2018						2017						2018			2017
	U.S.			Int'l			U.S.			Int'l

Weighted-average assumptions used to determine year-end benefit obligations
Discount rate		3.72	%		2.39	%		3.71	%		2.25	%		4.21	%		3.55	%
Compensation rate increase		–			2.23			–			2.26			–			–

(In millions)


U.S. pension plans	$	65.2
Int'l pension plans		10.7
U.S. postretirement health benefits		.4

(In millions)	2018			2017


Balance at beginning of year	$	21.1		$	21.3
Acquisitions		–			3.0
Charges, net of reversals		3.9			2.8
Payments		(5.0	)		(6.0	)

Balance at end of year	$	20.0		$	21.1

			Fair Value Measurements Using

(In millions)	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)

Assets
Trading securities	$	26.3	$	21.5	$	4.8	$	–
Derivative assets		3.6		.1		3.5		–
Bank drafts		23.0		23.0		–		–
Liabilities
Derivative liabilities	$	8.7	$	–	$	8.7	$	–
Contingent consideration liabilities		1.6		–		–		1.6

	Level 3 Liabilities

(In millions)	Contingent Consideration

Balance at December 30, 2017	$	45.0
Payments		(17.3	)
Adjustments(1)		(26.1	)

Balance at December 29, 2018	$	1.6

(In millions)


Antidilutive shares excluded from computation of net income per common share, assuming dilution	–	–	.2

(In millions)	2018		2017		2016


Stock-based compensation expense	$	34.3	$	30.2	$	27.2
Tax benefit		4.7		4.3		8.5




Risk-free interest rate	1.75	%
Expected stock price volatility	24.58	%
Expected dividend yield	2.58	%
Expected option term	6.5 years

	Number of options (in thousands)		Weighted-average exercise price		Weighted-average remaining contractual life (in years)	Aggregate intrinsic value (in millions)


Outstanding at December 30, 2017	543.6		$	44.22	4.94	$	38.4
Exercised	(32.0	)		30.69

Outstanding at December 29, 2018	511.6		$	45.06	4.00	$	22.4
Options vested and expected to vest at December 29, 2018	503.6			44.60	3.95		22.3
Options exercisable at December 29, 2018	370.5		$	34.06	2.70	$	20.3

			Weighted- average grant-date fair value


Unvested at December 30, 2017	485.1		$	68.15
Granted at target	121.6			120.25
Adjustment for above-target performance(1)	112.9			50.55
Vested	(236.4	)		50.53
Forfeited/cancelled	(30.4	)		79.41

Unvested at December 29, 2018	452.8		$	86.20

			Weighted- average grant-date fair value


Unvested at December 30, 2017	403.6		$	70.07
Granted at target	118.0			117.75
Adjustments for above-target performance(1)	177.9			63.75
Vested	(373.9	)		64.24
Forfeited/cancelled	(22.0	)		80.38

Unvested at December 29, 2018	303.6		$	90.33

			Weighted- average grant-date fair value


Unvested at December 30, 2017	140.4		$	72.62
Granted	22.9			106.44
Vested	(72.4	)		69.80
Forfeited/cancelled	(2.2	)		68.41

Unvested at December 29, 2018	88.7		$	83.72

(In millions)	2018		2017		2016


Restructuring charges by reportable segment and Corporate
Label and Graphic Materials	$	57.8	$	14.8	$	8.5
Retail Branding and Information Solutions		11.9		18.4		10.5
Industrial and Healthcare Materials		4.0		.2		.9
Corporate		–		–		–

Total	$	73.7	$	33.4	$	19.9

(In millions)	2018			2017		2016


U.S.	$	(7.3	)	$	49.0	$	17.9
International		562.1			540.5		459.2

Income before taxes	$	554.8		$	589.5	$	477.1

(In millions)	2018			2017


Balance at beginning of year	$	108.7		$	89.5
Additions for tax positions of the current year		11.5			14.1
Additions (reductions) for tax positions of prior years		(23.1	)		3.0
Settlements with tax authorities		(6.6	)		(1.6	)
Expirations of statutes of limitations		(5.9	)		(2.7	)
Changes due to translation of foreign currencies		(3.8	)		6.4

Balance at end of year	$	80.8		$	108.7

(In millions)	2018		2017		2016


Net sales to unaffiliated customers
U.S.	$	1,625.1	$	1,557.8	$	1,525.6
Europe		2,251.4		2,041.6		1,838.8
Asia		2,473.2		2,250.5		1,996.1
Latin America		490.0		476.4		450.5
Other international		319.3		287.5		275.5

Net sales to unaffiliated customers	$	7,159.0	$	6,613.8	$	6,086.5

(In millions)	2018		2017		2016


Property, plant and equipment, net
U.S.	$	317.3	$	286.4	$	278.5
International		820.1		811.5		636.7

Property, plant and equipment, net	$	1,137.4	$	1,097.9	$	915.2

(In millions)	2018		2017


Raw materials	$	236.2	$	214.6
Work-in-progress		196.7		179.8
Finished goods		218.5		215.2

Inventories, net	$	651.4	$	609.6

(In millions)	2018			2017


Land	$	28.0		$	31.1
Buildings and improvements		643.1			638.9
Machinery and equipment		2,231.1			2,188.2
Construction-in-progress		151.5			142.7

Property, plant and equipment		3,053.7			3,000.9
Accumulated depreciation		(1,916.3	)		(1,903.0	)

Property, plant and equipment, net	$	1,137.4		$	1,097.9

(In millions)	2018			2017


Cost	$	452.4		$	428.9
Accumulated amortization		(316.9	)		(301.8	)

Software, net	$	135.5		$	127.1